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                                                        ABSTRACT                
 
Benzoquinone (BQ) is an extremely potent electrophilic contact allergen that 
haptenates endogenous proteins through Michael addition (MA). It is also hypothesized 
that BQ may haptenate proteins via free radical formation. The objective of this study 
was to assess the inductive eﬀects (activating and deactivating) of substituents on BQ 
reactivity and the mechanistic pathway of covalent binding to nucleophilic thiols. The 
BQ binding by Cys34 on human serum albumin was studied, and for reactivity studies, 
nitrobenzenethiol (NBT) was used as a surrogate for protein binding of the BQ and 
benzoquinone derivatives (BQD). Stopped ﬂow techniques were used to determine 
pseudo-ﬁrst order rate constants (k) of methyl-, t-butyl-, and chlorine-substituted BQD 
reactions with NBT, whereas electron pair resonance (EPR) studies were performed to 
investigate the possible free radical mediated binding mechanism of BQD. 
Characterization of adducts was performed using mass spectrometry (MS) and nuclear 
magnetic resonance spectroscopy (NMR). The rate constant values demonstrated the 
chlorine substituted (activated) BQD to be more reactive toward NBT, than the methyl 
and t-butyl-substituted (deactivated) BQD, and this correlated with the respective EPR 
intensities. The EPR signal, however, was quenched in the presence of NBT suggesting 
MA as the dominant reaction pathway. MS and NMR results conﬁrmed adduct formation 
to be a result of MA of NBT onto the BQ ring with vinylic substitution also occurring for 
chlorine-substituted derivatives. The binding positions on BQ and NBT/BQD 
stoichiometric ratios were aﬀected by whether the inductive eﬀects of the substituents on 
ii 
 
the ring were positive or negative. The reactivity of BQ and BQD is discussed in terms of 
the potential relationship to allergenic potency.  Hammett and Taft (HT) constants were 
then used to estimate the influence of these substituents on chemical reactivity. HT values 
demonstrated chlorine substituted BQD to be more reactive than methyl substituted BQD. 
BQ and BQD dermal allergenicity, as evaluated in the murine local lymph node assay, 
(LLNA) was consistent with that predicted by reactivity and HT parameters. These 
results demonstrate the effect of substituents on BQ reactivity and dermal allergic 
sensitization, and suggest the potential utility of chemical reactivity data and HT values 
for electrophilic allergen identification and potency ranking. 
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                                                     CHAPTER ONE 
 
                         INTRODUCTION AND RATIONALE 
 
Allergic contact dermatitis (ACD) is caused by a wide range of chemicals after 
prolonged or repeated contact with the skin. Dermal exposure to chemicals can either be 
intentional (drugs and cosmetics), or unintentional (environmental pollutants and 
occupational exposure) resulting in ACD and other skin disorders which include irritant 
contact dermatitis (ICD) and in some cases immediate (Type I) allergic reactions 
(urticarial reactions). In developed countries, 15–20% of the population is allergic to one 
or more chemicals in their environment.
1
 Contact allergies are relevant in 20–50% of 
recognized occupational contact dermatitis cases and it is estimated that ACD accounts 
for 7% of all occupation related diseases.
2,3
 Several hundreds of chemicals have been 
shown to possess the ability to induce skin sensitization and ACD remains an important 
occupational and environmental health problem.
4
 There is no cure for ACD, and the 
pharmacological treatment still only targets the symptoms (e.g., anti-inflammatory 
corticosteroids). As an acquired disease, ACD is episodic and only avoidance of the 
offending agent can prevent elicitation of an ACD reaction.
5
 Over 13 million workers in 
the US are believed to be at risk from exposure to chemicals that are potential skin 
sensitizers and the level of compensation due to occupational contact dermatitis has been 
estimated to be greater than $1 billion/yr.
6
 The main causes of ACD in the USA are the 
members of the Rhus genus (poison ivy, poison oak, and poison sumac), 
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paraphenylenediamine, nickel, rubber compounds and ethylenediamine hydrochloride.
3,5
 
Quinones and quinone derivatives are another large group of chemicals that are widely 
used and amongst the most common contact allergens. ACD can develop anywhere on 
the body depending on exposure, but the hands are the sites most commonly exposed to 
chemicals and are thus most affected.  
1.1 Use of Quinones  
 
The use of quinone has traditionally been limited to dye production. More 
recently the utility of quinones has increased and become widespread. Quinones have 
been reportedly  used as analytical reagents,
7
 polymer modifiers,
8
 photoresistors,
9
 and 
catalysts.
10 
In agriculture they are being used as herbicides, fungicides, and plant-growth 
regulators. BQ and BQD are broadly used in tanning, dyes, production of chemicals (e.g., 
hydrogen peroxide), cosmetics and nonprescription forms of skin lightening cosmetics.
11-
13
 BQ is also used in hydroquinone production and as an intermediate in the production of 
a variety of substances, including rubber accelerators and oxidizing agents.
14-16
 To date,   
pharmaceutical applications of quinones have developed enormously, not only with the 
discovery of the vitamin Κ group, but also as the basic subunit which has found 
prominent applications in drugs such as antibiotics,
11
 antitumor compounds,
17,18
 and as 
antimalarial agents.
19
  
Quinones are also used extensively in temporary tattoo and hair dyes. The use of 
temporary tattoos and hair dyeing has become more fashionable, not only among adult 
women but also among adult men, teenagers, and children.
20
 Adverse skin reactions to 
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hair dyes also were reported in about 5% of individuals who have ever used hair dye and 
many of the hair dyes contain potent haptens such as para-phenylenediamine (PPD) and 
related substances.
21
 PPD is believed to be a pro-electrophilic sensitizer (prohapten) 
which can be oxidized either abiotically or enzymatically to a di-imine (DI), the nitrogen 
analogue of BQ, which can either act as a Michael acceptor electrophile or undergo 
hydrolysis to form BQ. Some BQDs, such as 2-tert-butyl-1,4-benzoquinone, are 
commercially available for use in cosmetics and as insect feeding deterrents on plants.
22
 
Quinones are a large class of compounds endowed with rich and fascinating chemistry.
23
 
Environmentally, quinones are conserved among  living organisms
2
 as they are found in 
arthropods, bacteria and plants. Quinones also play a pivotal role in biological functions, 
such as oxidative phosphorylation and electron transfer. Their role as electron transfer 
agents in primary metabolic processes like photosynthesis and respiration is vital to life. 
Quinones and quinine derivatives are most widely used as chemical defensive agents by 
arthropods, millipedes, beetles, arachnids and termites. Due to their industrial utility and 
natural abundance, it is most likely that the commercial use of quinones is going to 
persist and become more prominent. A larger percent of the world population will be thus 
exposed to BQ and BQD due to this widespread use of BQ and its products from homes 
to agriculture to industries. 
1.2 Development of Allergic Contact Dermatitis 
 
Development of ACD occurs in two steps (Figure 1.1); the first phase, termed induction 
or sensitization phase, occurs during the initial exposure to the offending chemical. Upon 
chemical absorption into the skin, this induction phase involves protein haptenation 
 4 
 
(reactivity), antigen presentation and development of antigen-specific T cells in draining 
lymph nodes.  The second phase, termed elicitation, occurs with re-exposure to the 
chemical allergen (hapten) resulting in migration of activated antigen-specific T cells to 
the site of exposure. Macrophages are recruited to the site of secondary contact, where 
interactions between T-cells and antigen-presenting cells can take place directly in the 
epidermis, thus initiating the inflammatory process, as shown in the elicitation stage in 
Figure 1.1. The allergic reaction is manifested as skin inflammation, edema and eczema. 
In both phases of ACD, the reaction of a low molecular weight chemical (<5000 Da) with 
epidermal protein/s resulting in an immunogenic adduct is the molecular initiating event 
(MIE) leading to immunological induction and elicitation of the allergic pathology.  
As such, the chemicals are too small to cause an immune response thus the need 
to haptenate endogenous proteins or peptides of the skin epidermis.
25
 Lipophilicity (logP 
∼2) to enable the chemical to pass through the skin epidermis26 is a helpful aspect 
distinguishing skin sensitizers from non-sensitizers. ACD is regarded as a delayed 
hypersensitivity reaction (type IV hypersensitivity), because the mechanism requires 24-
72 hours from exposure to full development, where development is mediated by antigen-
specific T-lymphocytes.
26
 A number of reviews have discussed the pathogenesis of ACD 
in greater detail.
27-29
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Figure 1.1: (Adapted from Basketter, et al. 2000) 
24
 Sensitization and elicitation phases 
of ACD. (1) Binding of haptens to epidermal proteins and other macromolecules. (2) 
Internalization of hapten-modified protein by Langerhans cells (LC)s. (3) Hapten-
induced activation of LCs that migrate to the lymphatic system and process hapten–
protein complexes as they mature into dendritic cells (DC)s. (4) Presentation of the 
hapten-protein complex (antigen) by DCs to naive T-cells. (5) Proliferation of antigen 
specific T-cells resulting in formation of memory T-cells. (6) Antigen-specific memory T-
cells leave the lymph node and enter the circulation. (7) Re-exposure to the hapten. (8) 
Release of cytokines and chemokines attracting cells to the skin from the circulation. (9) 
Inflammatory response within 24–72 hours with resultant symptoms of ACD.  
 
1.3 Develop Non-animal Based Assays 
 
It is very important that the safety of all chemicals encountered in occupational 
settings and as ingredients in consumer products be tested with respect to skin 
sensitization. Existing animal based assays such as the LLNA,
30
 which is based on the 
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proliferation of lymph node cells in the induction phase or the mouse ear swelling test 
(MEST)
30
 and the Guinea Pig Maximization Test (GPMT)
31
 which is based on the 
observation of the allergic responses in the elicitation phase of ACD, are widely used to 
screen for allergenic chemicals. Recent mandates in the US and Europe, under which 
committees such as the Interagency Coordinating Committee for the Validation of 
Alternative Methods (ICCVAM)
32
 and the European Centre for Validation of Alternative 
Methods (ECVAM),
33
 respectively, function, have increased emphasis on the 
development of non-animal methods for skin sensitization testing. Elsewhere, the 
Canadian Domestic Substance List, the European Union’s Registration, Evaluation, 
Authorisation and Restriction of Chemicals (REACH) and Cosmetics regulations, the 
Japanese Chemical Substance Control Law are other legislations that have necessitated 
the need for alternative methods that are anchored on robust science.
34
 In vitro cellular 
assays
35-37
 and peptide binding assays
38
 have been reported as potential replacements for 
animal based assays. The human Cell Line Activation Test (h-CLAT) and the Direct 
Peptide Reactivity Assay (DPRA) are notable examples of non-animal based assays that 
have been nominated to ICCVAM and ECVAM, and are undergoing validation before 
they can be adopted as alternative methods.
39
 Other reactivity assays utilizing cysteine, 
lysine, glutathione, and several model peptides have been developed and efforts are 
underway to validate them as alternative in chemico methods for screening skin 
sensitizers.
40-42
 Despite the headway that some of the current alternative assays have 
made in providing data that can be utilized to screen sensitizing chemicals with sufficient 
confidence there are challenges that these current methods have not been able to address 
including an in-depth understanding of the chemistry behind the reactivity assays. This 
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expertise is required to produce qualitative and quantitative data and also for 
determination of appropriate solvent systems for reactivity assessment. All aspects of 
reactivity such as selectivity (i.e., toward a particular amino acid target), reaction rate and 
the stability of the conjugate need to be considered in developing in chemico assays as it 
is often difficult to determine which aspect is relevant for in vivo potency. While most 
chemicals with reactive electrophilic centers will form covalent adducts with proteins, 
mechanistic pathways are different for different chemicals and this may determine the 
type and strength of adduct formed. The major limitation of the existing models in 
predicting or screening is their failure to predict the effects that substituents may have on 
the parent hapten. Do inductive effects result in lack of/decreased or increased skin 
sensitization potency of the derivative? Can these effects be included in developing an 
alternative model that can accurately predict potency as shown in the LLNA? The current 
alternative methods also lack the distinctive categorization of chemicals into their 
respective mechanistic domains.  
1.4 Reaction Mechanisms of Protein Binding  
 
Mechanistic domains are functional reaction groups that are targeted as alerting 
pointers to a chemical’s possible reaction with a protein and thus allow classification of 
chemicals based on their reaction chemistry. There are about 50 specific reactive protein 
binding mechanisms,
43
 which can be clustered under the general mechanisms shown in 
Table 1.1,  illustrating the common mechanistic domains and the electrophilic centers 
amenable to nucleophilic attack. More extensive analysis of mechanistic domains, their 
subcategories and ‘special cases (domain not clearly defined or >1 domain for a single 
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chemical)’ have been discussed in recent reviews40,44,45 and need to be utilized in 
categorization of test chemicals.  
Table 1.1: Common Mechanistic Domains (Nu is nucleophile and Pr is for protein) 
Mechanistic Domain 
Michael 
Acceptors 
Acylating 
Agents 
Schiff Base 
Formers 
SNAr 
Electrophiles 
SN1/SN2 
Electrophiles 
 
       
N
u -P
r
X
 
X = electron 
withdrawing 
group. 
 
N
u
 -P
r
O
X
 
X = electron 
withdrawing 
and a good 
leaving group. 
   
      
N
u
 -P
r
O
 
Attacking 
nucleophile is 
an amine (NH2-
) group. 
 
Nu -Pr
X
...Y2,Y1  
X = usually a 
halogen or 
pseudohalogen. 
Y1,Y2 = electron 
withdrawing group. 
      
       
X = usually 
electron 
withdrawing 
and a good 
leaving group. 
 
1.5 Benzoquinone Chemistry 
 
BQ (which was first synthesized in 1838)
46
 and BQD present an attractive model 
to study in terms of nucleophile reactivity and the contribution of substituents on the ring 
to BQ reactivity and potency. Quinones are conjugated cyclic diketones rather than 
aromatic compounds. Linear Combination Atomic Orbital-Molecular Orbital (LCAO-
MO) calculations for BQ have shown that the distribution of π-electron density is very 
uneven, as depicted in Figure 1.2. 
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Figure 1.2: Shows the uneven distribution of π-electrons. 
The wide variation in the electron density distribution of quinones explains the 
broad spectrum of reactivity of this class of compound. In fact, quinones participate in an 
enormous number of homolytic and heterolytic reactions.
47 
 In heterolytic reactions, 
quinones which are potent oxidizing agents are proposed to be Michael acceptors (MA) 
and are stabilized by conjugation. Depending on the quinone and the site of reduction, 
reduction can either re-aromatize the compound or break the conjugation. They can also 
undergo enzymatic (i.e., P450/P450 reductase) and nonenzymatic redox cycling with 
their corresponding semiquinone radical and as a result generate superoxide anion 
radicals (Figure 1.3).
48
 
 Covalent binding of BQ and BQD species to cellular nucleophiles cause damage. 
For example, they react readily with sulfur nucleophiles, such as glutathione (GSH) or 
cysteine residues on proteins, leading to depletion of cellular GSH/thiol levels and/or 
protein alkylation. In addition, some quinones can react with nucleophilic amino groups 
on proteins or DNA.
48
 The reactions of BQ and BQD with proteins lead to the formation 
of covalent bonds with bond energies ranging from 200 to 420 kJ/mol.
44
 Chemically, the 
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skin can best be described as a nucleophilic environment, rich in water and lipids with 
electron-rich nucleophilic functional groups present on the proteins.  
 
                               
Figure 1.3: Alkylation(by R)and redox cycling of quinone,  generating adducts and ROS. 
Asterisk indicates that this reaction only occurs for quinones with autoxidase.
48
  
 
1.5.1 Michael Addition Reactions 
 
Among the molecular mechanisms that lead to the molecular initiating events of 
protein alteration is Michael addition, which results in the formation of covalent adducts 
at a soft electro(nucleo)philic centers without expulsion of  leaving groups from the 
molecules. Electrophiles acting in this manner are typically organic materials that contain 
olefinic π-bonds polarized by a neighboring electron-withdrawing substituent. 
Electro(nucleo)philic interactions of Michael acceptors include the addition of an -SH 
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group to the β–carbon atom (β-C atom) of a carbon–carbon double (C=C) or triple (C C) 
bond. Having a polarized R group and an unsaturated configuration results in a relatively 
diffuse and polarizable electron density of the olefinic π-bond, placing Michael acceptors 
among the softest electrophiles.
49
 Benzoquinone (BQ) is thus chemically reactive as a 
Michael acceptor electrophile. Identification characteristics of a Michael acceptor include 
a double or triple bond with an electron-withdrawing substituent X, such as –CHO, -
COR, -CO2R, -CN, -SO2R, or -NO2,
50
 where R is a hydrocarbon as shown by examples in 
Figure 1.4. 
   
Figure 1.4: Examples of Michael acceptor compounds. 
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1.5.2 Free Radicals in Biology 
 
Free radicals are reactive atoms, ions or molecules that have an odd number of 
electrons in one of their orbitals and have the ability of independent existence.
50
 The 
presence of unpaired electrons makes radicals readily react with a wide range of 
molecules in a way as to fill their half empty orbitals with electrons.
51
 The mechanism of 
free radical production is an endless chain, which produces many free radicals that are 
responsible for oxidative stress in the biological systems.  
It has long been known that electron acceptors such as quinine(Q) and its 
derivatives are reduced in the presence of an electron donor like hydroxide ion (OH
-
) to 
yield the corresponding one-electron reduced radical species and semiquinone radical 
(SQ
•-
)
52
anions. The semiquinone radicals are strong reducing agents in aqueous solution 
at physiological pHs and reduce dissolved oxygen to form superoxide and other 
biologically active reactive oxygen species (ROS).
53
 In relation to ACD, free radical 
mechanism may be one of the mechanisms through which contact allergens bind proteins 
even though evidence implicating free radical formation in ACD is scant.  
1.5.3 Conjugation via MA versus Free Radical Mechanism 
 
The hyperfine coupling constant, An, is directly proportional to the probability of 
finding the unpaired electron at the nucleus, n. Hyperfine couplings observed in EPR 
spectra of the radical anion of a molecule are also related to the site of reaction of 
nucleophiles on the neutral molecule. When the unpaired electron is in a conjugated π 
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molecular orbital consisting of aromatic carbons or hetero atoms, the McConnell equation 
(equation 1.1) predicts the 
1
H hyperfine coupling constant, AH: 
                                AH = Qρ                                                   (1.1) 
where Q is 25 + 5 G for carbon, and ρ is the unpaired π-electron density at the aromatic 
carbon nucleus to which the H atom is bonded. This means that the hyperfine couplings 
are related to the spin densities at a given site through the McConnell equation.
54
 The 
singly occupied orbital of the radical anion is the lowest unoccupied molecular orbital 
(LUMO) of the neutral molecule. Thus, the site of largest hyperfine coupling in the 
radical anion is also the site of attack of a nucleophile on the neutral molecule. This 
means that there is a relationship between MA and radical anions,
55
 and the studies herein 
investigate this link.  
1.6 BQ Reactivity and SS Potency 
 
The use of in vivo methods to screen allergenic chemicals requires a large number 
of animals. Thus, the goal of these reactivity studies is to enable screening of chemicals 
for skin sensitizing potential without or with minimal use of animals. Epidermal 
absorption of a chemical and its subsequent reactivity is influenced by physicochemical 
parameters, such as octanol-water partition co-efficients and substituent effects. 
Measuring reactivity rates is a direct way of quantifying the contribution of 
physicochemical parameters, which could otherwise be estimated mathematically from 
the known mechanism of action, applying established principles of chemistry.
56
 In this 
study, the derived reactivity constants were correlated with skin sensitization potency, 
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quantified by the murine LLNA data on BQ and BQD electrophiles. Another set of 
predicted EC3 values from a quantitative mechanistic model (QMM) was based on the 
Hammett (σ-) values for the activating and deactivating groups and the Taft (σ*) values 
for the leaving group. These values were integrated into the QMM equations for Michael 
acceptors to predict the EC3 values for the BQD. Thus the other aim in this study is to 
gather further evidence regarding the role of reaction chemistry in determining skin 
sensitization potency, by developing a targeted QMM for LLNA data on BQD which are 
in MA domain.  
 
Figure 1.5: Benzoquinone and methyl or t-tert-butyl substituted benzoquinone derivatives 
and Chlorine substituted benzoquinone derivatives used in this study. 
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In order to analyze how chemical reactivity and sensitizing capability depend on 
the structure of the contact allergen BQ, a series of structural derivatives of BQ (Figure 
1.5) was used. Their reactivity was evaluated via experiments with a thiol (NBT) and 
changes in absorbance due to depletion of thiol were monitored. To investigate if the 
sensitizing potency of these analogues is related to their reactivity an animal model 
(LLNA) was used. 
The goal of this project was to investigate and determine the inductive effects of 
substituents on benzoquinone reactivity and subsequent skin sensitizing potency. The 
inductive effects on BQD were used to develop a chemical reactivity based predictive 
model for skin sensitization, which was evaluated using the murine local lymph node 
assay (LLNA), a well accepted assay for allergen identification. The aims of this thesis 
were; (i) to determine the potential reaction mechanisms and the relative rate constants of 
BQ and BQD binding to NBT as a surrogate for protein haptenation and (ii) to perform 
LLNA for BQ and BQD to test the predictive power of the reactivity data and the 
potential utility of the reactivity approach as an alternative method for identification of 
skin sensitizers and potency assessment. The reactivity constants determined in (i) were 
used to predict the LLNA EC3 (threshold dose) values for the BQD. Using BQ as a 
positive control, the LLNA for six BQD (3 with electron withdrawing groups + 3 with 
electron donating groups) was performed and the determined EC3 values compared with 
the predicted EC3 values from a previously published reactivity assay.
57
 Finally the BQD 
were ranked according to their skin sensitization potency was performed.  
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                                                    CHAPTER TWO 
                         INSTRUMENTATION, MATERIALS AND METHODS 
 
2.1 INSTRUMENTATION 
 
2.1.1 Conventional UV/Vis Spectrophotometry 
 
Reactions which occur in minutes were measured using either a Perkin Elmer 
Lambda 25 UV/Vis spectrophotometer or a Beckman DU800 both featuring a double-
beam, total reflection system within the range 200 to 800 nm.  For instruments, 
holographic grating was used as the monochromator and two radiation sources, a 
deuterium lamp (UV) and a halogen lamp (visible range) were used in sequence as the 
polychromator light sources. The Perkin Elmer spectrophotometer was interfaced to a 
Pentium III computer and uses the UV WinLab Software for data collection and analyses 
while the Beckman spectrophotometer is interfaced to an IBM PC computer and used the 
DU Series 800 Software. Path length of the cuvette was 1 cm. The Beckman spectrometer 
gave the option of using either a single cell holder or a multi-cell holder (maximum of 6), 
depending on the experiment. Constant temperature was maintained by use of a 
circulating water bath attached to the cell holders. 
2.1.2 Stopped Flow Spectrophotometry 
 
All rapid reactions (with time scales as short as 2-10 seconds) were measured 
using the stopped-flow technique, which can follow reactions with time scales as short as 
 17 
 
milliseconds. The Hi-Tech Scientific SF61 – DX2 Double mixing stopped-flow 
spectrophotometer was used for the acquisition of absorbance data. The instrument was 
interfaced to a Pentium III computer via a 413 kHz 16 bit A/D converter to enable the 
conversion of data to digital form. A high efficiency mixer mix small volumes of 
solutions, which were driven into it from high performance syringes. Small volumes of 
solutions are driven from high performance syringes through high efficiency mixer(s). 
The sample handling unit (Figure 2.1) facilitates both the single mixing of two reagents, 
using only one of the drives, and double mixing of three reactants by a push-push mode 
of operation. Double mixing mode enables transient species formed by mixing reactants 
in A and B to be subsequently mixed with a third reactant, C, after a delay period. 
Reactant reservoir D is reserved for the buffer and this will push the premixed solutions 
A and B (from mixer 1) to a second mixer (mixer 2) where it reacts further with reactant 
C. The resultant mixture passes through a measurement flow cell and into a stopping 
syringe where the flow is stopped. Just prior to stopping, a steady state flow is achieved. 
The solution entering the flow cell is only milliseconds old. The age of this reaction 
mixture is also known as the dead time of the stopped-flow system. As the solution fills 
the stopping syringe, the plunger hits a block, causing the flow to be stopped 
instantaneously.  Reactions in which three or more reactants that require separate mixing 
prior to introduction into the observation chamber are analyzed using the double mixing 
feature of the SF61- DX2. The kinetics of the reaction can be measured in the cell using 
the appropriate techniques.
58
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Figure 2.1: Sample Handling Unit (SHU) flow circuit diagram for the SF61-DX2 Hi-
Tech KinetAsyst stopped-flow spectrometer. [Courtesy of Hi-Tech Scientific operator’s 
Manual]
58
 
 
2.1.3 Nuclear Magnetic Resonance Spectrometry (NMR) Spectroscopy 
 
 
Structural characterization and verification of products and intermediates were 
conducted using a Bruker  AMX-400 MHz Nuclear Magnetic Resonance (NMR) 
spectrometer. Each atom possesses a nucleus surrounded by an electron cloud. For the 
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hydrogen atom, the nucleus is composed of a single proton which possesses a property 
called spin. Nuclei such as the hydrogen nucleus, with unpaired spins of protons and 
neutrons, will possess an overall nuclear spin, thus creating a nuclear magnetic dipole 
moment, where the inherent magnitude of the dipole is a nuclear property commonly 
referred to as the dipole moment, μ. Thus, if the nucleus is placed in a magnetic field, the 
nuclear dipole moment will proceed about the magnetic field. The z component of the 
nuclear magnetic moment of the nucleus can either be aligned parallel to the external 
field (low energy) or can be anti-parallel to the external field (high energy). A particle in 
the low energy state can be excited to the higher energy state, when it absorbs a photon of 
frequency    , where the energy of the photon is the difference in energy between the 
two states given by 
                                              E = h                                    (2.1) 
 
The variable   is also known as the Larmor frequency or resonance frequency.59 
Hence it is the nuclei of atoms that are involved in the absorption process in NMR, unlike 
in UV/Vis and IR absorption. The signal in NMR spectroscopy is due to the disparities in 
the energy absorbed by the nuclei as they are excited from the lower energy state to the 
higher energy state, and the energy emitted by the nuclei as they relax from the higher 
energy state to the lower energy state.
59
 The intensity of the signal is proportional to the 
population difference between the two states and the area under a given peak is directly 
proportional to the number of that type of protons in the molecule. The frequency of 
electromagnetic radiation necessary for resonance to occur depends on both the strength 
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of the external magnetic field, and on the characteristics of the nucleus being studied.
59
 
The electron cloud surrounding the nucleus tends to shield it from the full strength of the 
applied magnetic field. The greater the electron density, the greater the shielding, thus 
nuclei which are in electron-rich environments will undergo transition at a higher applied 
field than nuclei in electron-poor environments. 
 
Similarly, nuclei that are adjacent to electronegative atoms, are deshielded and 
undergo transitions at a lower applied filed. The resulting shift in the NMR signal for the 
given nuclei is referred to as the chemical shift.
59
 Spin-spin coupling
59
  occurs between 
chemically inequivalent nuclei that are close enough to each other to exert an influence 
on each other’s effective magnetic field, giving rise to the various splitting patterns 
observed in an NMR spectrum. Such an effect is observable if the distance between the 
chemically inequivalent nuclei is less than or equal to three bond lengths.
59
 In some 
molecules, certain protons may appear to be inequivalent to other protons in a particular 
rotamer, although they become equivalent if rapid rotation occurs. In some instances, this 
does not remove the inequivalence and the protons can be interchanged via symmetry 
operations. This inherent asymmetry may result in observable differences in the chemical 
shifts.
60
 
1
H-NMR spectra were recorded with a Bruker AMX-400MHz spectrometer 
using CDCl3 and D2O as solvents. Chemical shifts were reported as values in ppm 
relative to CHCl3 (7.26) in CDCl3 and TMS which was used as an internal standard(0).
61
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2.1.4 Electron Paramagnetic Resonance (EPR) Spectroscopy 
 
Electron Paramagnetic Resonance (EPR) was discovered in 1944 by E.K. 
Zavoisky.
62
 The principles of EPR are quite analogous to those of NMR. Thus the 
electron has an intrinsic magnetic moment (𝜇e = gβeS). Where g =2.0023, βe = 
((eh)/(4πmc) = 9.27 x 10-24 J T-1 (Bohr magneton, where e is the elementary charge, h is 
the reduced Planck constant, m is the electron rest mass and  is the speed of light) and  S 
= (1/2). The first order Zeeman Effect splits the two ms states of the unpaired electrons in 
a paramagnetic material. 
 
 
 
                                                 
 
 
 
 
 
 
Figure 2.2: Zeeman splitting of the two spin Eigenstates of an electron in an external 
magnetic field. The classical analogue to bar magnets is indicated on the right. 
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In EPR spectroscopy the energy differences, ΔE, due to interaction of unpaired 
electrons in the sample with a magnetic field produced by a magnet are studied. 
Absorption occurs when ΔE equals the microwave energy, hν. 
Equation 2.2 and Figure 2.2 describe the general principle of EPR.      
                                                   
                                                       ΔE = hν = gβeH                                               2.2 
 
where h is Planck’s constant, ν is microwave frequency, β is Bohr magneton (a constant 
related to electron charge and mass), H is magnetic field at which resonance occurs and g 
is a spectroscopic factor, which is a characteristic of a given paramagnetic center. The 
shape and width of the spectral line as well as the hyperfine (splitting) and area under the 
absorption curve are other important parameters in EPR spectroscopy. The area which is 
the double integral of the 1st derivation curve is proportional to the amount of a given 
paramagnetic center (spin) present in the resonator cavity of the EPR instrument.  
 
EPR spectroscopy was carried out using a Bruker (Fremont, CA) EMX 
spectrometer equipped with a high-sensitivity cavity and an Aqua-X sample holder. 
Spectra were obtained at room temperature. Typical EPR parameters were as follows: 
100 G sweep width (for the spin trapping experiments with 5,5-dimethyl-1-pyrroline N-
oxide, (DMPO)); 9.77 GHz microwave frequency; 32 mW power; 2×10
5
 receiver gain; 
modulation frequency of 86 kHz; modulation amplitude of 2 G; with the conversion time 
5 ms and time constant being 10 ms with 200 X-scans for each 512 point spectrum. 
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2.1.5 Electrospray-Ionization Mass Spectrometry (ESI-MS) 
 
Mass spectrometry (MS), is an analytical technique that sorts and measures 
ionized molecules based on their mass-to-charge ratios. This spectrometric method works 
on the basic principle of separation of ions of a compound on the basis of their mass-to-
charge ratio (m/z). ESI uses electrical energy to assist the transfer of ions from solution 
into the gaseous phase before they are subjected to mass spectrometric analysis. Ionic 
species in solution can thus be analysed by ESI-MS with increased sensitivity. Neutral 
compounds can also be converted to ionic form in solution or in gaseous phase by 
protonation or cationisation (e.g., metal cationisation), and hence can be studied by ESI-
MS.  
Figure 2.3: Schematic representation of the electrospray ionization(ESI) process.
63
  
The transfer of ionic species from solution into the gas phase by ESI involves three steps: 
(1) dispersal of a fine spray of charge droplets, followed by (2) solvent evaporation and 
(3) ion ejection from the highly charged droplets (Figure 2.3) into the tube, which is 
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maintained at a high voltage (e.g., 2.5 - 6.0 kV) relative to the wall of the surrounding 
chamber.  
 
A mist of highly charged droplets with the same polarity as the capillary voltage 
is generated. The application of a nebulizing gas (e.g. nitrogen), which shears around the 
eluted sample solution, enhances a higher sample flow rate. The charged droplets, 
generated at the exit of the electrospray tip, pass down a pressure and potential gradient 
toward the analyzer region of the mass spectrometer. With the aid of an elevated ESI-
source temperature and/or another stream of nitrogen drying gas, the charged droplets are 
continuously reduced in size by evaporation of the solvent, leading to an increase of 
surface charge density and a decrease of the droplet radius. Finally, the electric field 
strength within the charged droplet reaches a critical point at which it is kinetically and 
energetically possible for ions at the surface of the droplets to be ejected into the gaseous 
phase. The emitted ions are sampled by a sampling skimmer cone and are then 
accelerated into the mass analyzer for subsequent analysis of molecular mass and 
measurement of ion intensity. The mass spectrum is a graphical display of the relative 
abundance of ion signals against the m/z ratios. It is a common practice that the highest 
signal is taken as 100% abundance and all the other signals are expressed as a percentage 
of this.
64
 
Mass spectra of products from reaction mixtures were taken on a high-resolution 
(m/∆m = 30 000) Thermo Scientific LTQ-Orbitrap Discovery mass spectrometer (San 
Jose, CA) equipped with an electrospray ionization source. All mass spectrometer 
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samples were dissolved in MeOH/H2O (1:1) mixture. The ESI-MS source parameters 
were set as follows: spray voltage of 2.5 kV, spray current of 1.96 µA, sheath gas flow 
rate of 20, auxiliary gas flow rate of 0.01, capillary voltage of -16 V, capillary 
temperature of 300 
o
C and tube lens of -115 V. Detection was carried out in the negative 
ionization mode (-ESI) for 2 minutes in mass range m/z of 100-1000. The detection 
parameters were set up as follows: Analyzer was  fourier transform mass spectrometry 
(FTMS), negative polarity; mass range was normal with resolution of 30 000 and scan 
type was centroid. 
2.2. MATERIALS AND METHODS 
 
2.2.1 Chemicals 
 
All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO) and were used 
without further purification unless otherwise noted. 
2.2.2 Thiol Binding Determination 
 
 The method reported by Schultz et al.
41
 was used with slight modification. 
Briefly, Ellman’s reagent (5,5'-dithiobis-(2-nitrobenzoic acid; DTNB)) and cysteine (5 
mM) stock solutions were prepared in a 50 mM ammonium carbonate buffer (NH4)2CO3; 
pH 7.4) buffer. Cysteine (Cys) standards from 50 to 250 μM were reacted with 1 mM 
DTNB at room temperature in a total volume of 2 mL. Absorbance readings taken at 412 
nm (𝝐412 nm = 14,150 M
-1
cm
-1
) after 15 min were plotted against the final cysteine 
concentration to give the standard curve (Figure 2.4). This calibration curve was used to 
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determine Cys and glutathione (GSH) binding to BQ following reaction of 0.125 mM 
Cys/GSH with 0.625 mM BQ for 2 h with subsequent addition of 0.625 mM DTNB for 
15 min. The calibration curve was also used to determine human serum albumin (HSA) 
reduced sulfhydryl concentration ([SH]/[HSA]) following reaction of 0.8 mg/mL (≈ 11.9 
µM) HSA with 0.625 mM DTNB for 15 min with subsequent absorbance readings at 412 
nm. BQ (0.625 mM) was incubated with 0.8 mg/mL (≈ 11.9 µM) HSA for 2 h with 
subsequent addition of 0.625 mM DTNB to measure the loss of Cys34 reactivity.  
Figure 2.4: Calibration curve of Cysteine (Cys) standards from 0 to 100 μM were 
reacted with 1 mM DTNB at room temperature in a total volume of 2 mL. Absorbance 
readings taken at 412 nm after 15 min were plotted against the final cysteine 
concentration to give the standard curve. Equation of line: y = 13650 x – 0.0079 (R2 = 
0.996). 
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2.2.3 Preparation of Reduced Thiols 
 
The reconversion of the Cys34 residue on HSA to the free sulfhydryl form was 
performed by incubating equal volumes of 4 mg/mL HSA with 4 mM dithiothreitol 
(DTT) in (NH4)2CO3 buffer (50 mM) at room temperature for 3 h, followed by dialysis 
(molecular mass cutoff of 3500 Da) in 2 L of 50 mM (NH4)2CO3 for 48 h with three 
buffer changes during that period to ensure complete removal of DTT. The post-dialysis 
HSA concentrations were determined using the Bradford assay
65
 with human serum 
albumin (HSA) as the standard protein. HSA thiol concentrations were determined using 
Ellman’s reagent as outlined above and the extent of thiol blocking with BQ was 
measured with Ellman’s reagent and compared with blocking performed with the thiol 
specific reagent, N-ethylmaleimide (NEM). 
2.2.4 Extent of BQ Binding to Cys34 in HSA 
 
A stock solution consisting of 4 mg/mL HSA was prepared in 50 mM (NH4)2CO3. 
Then, 0.8 mg/mL (≈ 11.9 µM) HSA was incubated with 250 µM BQ for 1 h on a shaker 
at 37 °C followed by dialysis for 48 h. Loss of DTNB reactivity (as described above) was 
used to determine loss of thiol reactivity as a result of BQ covalent binding. As controls, 
HSA thiol concentrations were determined for (i) fresh HSA in buffer that was not 
incubated or dialyzed, (ii) HSA (in the absence of BQ) that had been incubated under the 
same conditions (as the BQ-treated HSA) and dialyzed, and (iii) HSA which had been 
reduced by dithiothreitol (DTT) and dialyzed. A comparison of the kinetics of the 
reaction of DTNB with (i) reduced HSA, (ii) reduced and dialyzed HSA, and (iii) reduced 
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HSA incubated with BQ with subsequent dialysis was performed. Human albumin has 
only one free thiol, Cys34. To ascertain the Cys34 as the BQ-targeted residue, the thiol 
specific blocking reagent N-ethylmaleimide (NEM) was reacted with reduced HSA (as a 
positive control) prior to reactions with DTNB. DTT-reduced HSA (0.8 mg/mL, 11.9 
μM) was reacted with 250 µM NEM for 30 min in a pH 7.4 (NH4)2CO3 buffer at room 
temperature with subsequent dialysis. Aliquots were taken for [SH]/[HSA] determination 
with DTNB. HSA pretreated with BQ and incubated with DTNB was also subjected to 
the same analysis. 
2.2.5 Extent of BQ Binding to Primary Amines in HSA 
 
  A stock solution consisting of 0.8 mg/ml HSA prepared in PBS (pH 7.4) was 
incubated with 250 µM BQ for 1 h at room temperature followed by dialysis for 48 h 
against PBS buffer. The trinitrobenzene sulfonic acid (TNBS) amine specific probe assay 
was performed on HSA and HSA-BQ conjugates.  HSA (500, 400, 200, 100, 50 µg/mL) 
were prepared in PBS buffer (pH 7.4). TNBS (5% w/v) was diluted 1: 5.48 with 0.1 M 
borate buffer (pH 9.3). To 500 µL of HSA and HSA-BQ, 12.5 µL of TNBS was added, 
mixed well and left to react for 30 minutes and absorbance was measured at 420 nm.  
2.2.6 Whole Human Fresh Blood Collection and Serum Separation 
 
  Whole blood was drawn into 10 mL BD Vacutainer Serum Separation Tubes 
containing gel and clot activator transport and inverted four times for the blood to mix 
with the tube additives. The blood was allowed to sit for 30 min at room temperature for 
clotting to occur. Serum was separated by centrifugation of the tubes at 1000 g for 10 min 
 29 
 
at 4°C. The serum was transferred into plastic tubes using glass pasteur pipettes and 
aliquoted before determination of protein concentration. The aliquoted samples were 
stored at -20°C. The Cys-DTNB calibration curve was used to determine serum total 
sulfhydryl concentration ([SHT]) following reaction of 0.1 ml of 0.1 mg/mL serum 
protein with 0.4 ml of 0.5 mM DTNB for 15 min with subsequent absorbance readings at 
412 nm. The calibration curve was also used to determine loss of [SHT] and the ratio 
[SHr]/[SHT] (SHr = blocked thiol) when serum was incubated with BQ prior to DTNB 
reactivity. To measure binding of BQ and NEM to high molecular weight thiols dialysis 
of the serum samples was performed for 48 h against PBS to remove low molecular 
weight thiols prior to incubation with BQ/NEM and subsequent determination of thiol 
binding with DTNB. The ratio of blocked thiol post dialysis (SHd) to total thiol of the 
control post dialysis SHTd (= [SHd]/[SHTd]) was also determined. 
2.2.7 BQ and BQD Binding Kinetic Studies 
 
Reaction kinetics were measured on a Hitech Scientific (Bradford-on-Avon, UK) SF-
61DX2 double-mixing stopped-flow spectrophotometer with an F/4 Czerny-Turner MG-
60 monochromator and a spectra scan control unit. The signal from the 
spectrophotometer was amplified and digitized via an Omega Engineering DAS-50/1 16-
bit A/D board interfaced to a computer for storage and data analysis. Reaction progress 
was followed by monitoring the loss of free thiol on NBT at 412 nm, where it has its 
highest molar absorptivity coefficient (ε) as previously described.66 
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Test chemicals listed in table 2.1 were dissolved in acetonitrile at concentrations 
ranging from 0.01 to 10 mM. These solutions (5 μL) were combined with 5 μL of 0.1 mM 
NBT in phosphate buffer (pH 7.4) in a sealed reaction cell with rapid mixing. Absorbance 
readings were collected after a dead time of 1 ms. Control experiments contained test 
chemical in acetonitrile/phosphate buffer to determine background absorbance. Five 
replicates were performed for each chemical at each concentration. The temperature was 
maintained at 25°C in the observation cell with a VWR International (Radnor, PA) 
circulating water bath. 
2.2.8 Sample preparations and solvents used in Electron Paramagnetic Resonance 
(EPR) Spectroscopy 
 
The final concentrations of BQD derivatives were 50 μM and DMPO was 100 
mM unless specifically mentioned. Buffer solutions were prepared by adjusting with 5 M 
sodium hydroxide solution or 1 M hydrochloric acid. The effect of NBT on the 
generation of free radicals was studied by incubating 0.1 mM NBT with 1 mM BQD + 
100 mM DMPO. Spectral simulations of EPR spectra were performed using WinEPR 
program developed by Bruker and the coefficients of simulated spectra were > 0.96. 
 
2.2.9 Sample Purification Methods for Samples used for Mass Spectroscopy and 
Nuclear Magnetic Resonance 
 
  Reagents were from Sigma Aldrich and used as supplied. The reaction mixture of 
six-fold molar excess of NBT samples were incubated in phosphate buffer pH 7.4 for 24 
hours. The reaction mixture was purified by preparative TLC (10-20% EtOAc/80-90% n-
 31 
 
hexane) for samples of compounds 3-7 to obtain the products in a pure state whilst 
compound 8 was separated using Teledyne Isco Combflash Rf 200 PSI. After 
completion, solvents were evaporated using a rotor evaporator, and the products were 
dissolved in appropriate solvent for spectroscopy analysis.  
2.2.10 Approach for QSAR Analysis 
 
Hammett and Taft substituent constants were taken from Perrin et al.
67
   The 
structures are given in Figure 2.5. The reaction sites are indicated by the arrows. For 
Hammett constants compounds 2-MBQ, 2,5-DMBQ, 2,6-DMBQ, 2-CBQ, 2,5-DCBQ 
and 2,6-DCBQ were used whilst for Taft constants test compounds BQ, 2-CBQ, 2,5-
DCBQ and 2,6-DCBQ were used. 
 
 
* 2-tBBQ produced clinical signs of systemic toxicity including weight loss, lethargy and 
ruffled fur that gave poor dose-dependent proliferative responses and preventing a 
reliable EC3 determination.  
Figure 2.5: Benzoquinone and its derivatives.  The arrows are the sites of nucleophilic 
attack.  
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2.2.11 Local lymph node assay 
 
 
Figure 2.6: Overview of the LLNA and the dose response curve. 
 
The Interagency Coordinating Committee on the Validation of Alternative 
Methods ( ICCVAM) validated LLNA protocol
68
 (NIOSH Local Lymph Node Assay 
Procedure (SOP # ACI00043) was used to determine the EC3 values of BQ and BQD, 
with the exception that Balb/C mice were used. 
Female BALB/c mice were purchased from Taconic (Hudson, NY, USA). Animals were 
6–8 weeks old upon arrival and allowed to acclimate for a minimum of 10 days. Animals 
were housed in the Association for Assessment and Accreditation of Laboratory Animal 
Care International-accredited animal facility at National Institute for Occupational Safety 
and Health (NIOSH), Morgantown, WV, USA. Animals were housed under controlled 
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environmental conditions in High Efficiency Particulate Act (HEPA)-filtered ventilated 
polycarbonate cages on autoclaved hardwood beta-chip bedding and provided food and 
autoclaved tap water ad libitum. All animal procedures were reviewed and approved by 
the NIOSH Animal Care and Use Committee. 
The LLNA test (Figure 2.6) was conducted in three independent blocks, each of 
which contained solvent controls, assay of 2 BQDQ and BQ as the positive control. After 
grouping mice into homogenous groups (n = 4) based on their weight, mice were dosed 
with 25 μL/ear of a test chemical in acetone olive oil (AOO; 4:1). The negative vehicle 
control group was dosed with AOO.  The vehicle and test chemicals were applied on the 
dorsum of both ears. Two hundred μL of 20 μCi 3H-TdR in 0.01 M PBS was injected into 
the tail vein on day 6, and after 5 h the mice were euthanized via CO2 inhalation. Left and 
right draining auricular lymph nodes were excised and pooled for each animal. Single cell 
suspensions were made and following overnight protein precipitation using 5% TCA, 
samples were counted on a Packard Tri-Carb 2500TR (Meriden, CT) liquid scintillation 
analyzer with background subtraction. Stimulation indices (SI) were calculated by 
dividing the mean disintegrations per minute (DPM) per test group by the mean DPM for 
the vehicle control group. A test chemical is thus considered to be a sensitizer if it has a 
three-fold SI over that of the vehicle (which is assigned an SI of 1). The concentration 
responsible for a three-fold stimulation is thus termed the EC3 value of the 
chemical.
35,69,70
 The EC3 value is usually calculated using a defined dose-response curve 
and the linear interpolation method (Figure 2.6 insert) published by Basketter,
71
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  EC3 = c + [(3 – d)/(b – d)] x (a – c)   (2.3) 
 
where a = the lowest concentration giving stimulation >3; b = the actual stimulation 
index caused by a; c = the concentration with a stimulation index of < 3; and d = the 
stimulation index caused by c. The values represent stimulation indexes below and above 
the 3-fold stimulation index. 
In our case the EC3 was estimated by the benchmark approach, by fitting a nonlinear 
regression model to the data of all individual animals.  
2.2.12 Statistical Analysis  
 
LLNA: The structure of these experiments was a nested design. Mice were 
randomly placed into treatment groups, which included solvent control, positive control, 
+ hapten groups. Lymph node cell proliferation was measured as described above. A 
sample size of four per treatment group provides greater than 95% power to find a change 
in lymphocyte proliferative activity of at least 50%, based on a treatment variance of 
20%, which iwas based on previous studies. Analysis was performed using the Mixed 
Procedure on an SAS platform to perform a hierarchical analysis of variance. Results will 
be considered significant if p < 0.05. 
The log P values were calculated from structure using ADMET® (MedChem-Designer) 
software
72
 and the values are given as mean ± SD. SigmaPlot (Version 12.0 Systat 
Software Inc.) was used for statistical analysis and graphical presentation.
73
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CHAPTER THREE 
 
REACTIVITY AND FREE RADICAL FORMATION 
 
3.1 INTRODUCTION 
 
The interaction of skin sensitizers with proteins, peptides, and model nucleophiles 
representing cutaneously available proteins has been reported to be predominantly 
covalent bonding between electrophiles (E
+
) and nucleophiles. It is generally agreed that 
low-molecular mass xenobiotics such as BQD (<500 Da) do not have a sufﬁcient 
molecular volume, once they have penetrated the stratum corneum  into the epidermis, to 
stimulate a cellular and/or antibody immune response. Therefore, the xenobiotic has to 
bind to a protein to form a macromolecular immunogen in the form of a hapten–carrier 
complex, a postulation which has come to be commonly termed the “hapten hypothesis.”  
Reactivity of BQ to thiols (e.g., Cys34 on HSA) and to primary amines (on HSA) was 
tested.  The kinetic spectrophotometric chemoassay for the assessment of skin sensitizers 
by reactivity toward 4-nitrobenzenethiol (NBT) as a surrogate protein binding was 
utilized with BQ and BQD. Stopped-flow techniques were used to monitor the depletion 
of NBT at 412 nm from which NBT depletion rate constants of reaction were obtained 
and ranged from seconds to minutes to reach completion. It was  previously suggested by 
Christensson et al. (2006),
74
 that  semiquinone radicals may act as a hapten. The 
relationship between semiquinone radicals and reactivity was examined. Semiquinone 
radicals were detected using EPR, spectroscopy.  EPR spectroscopy is a technique that 
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provides unique insight into the redox biochemistry, due to its ability to distinguish and 
quantify different reactive species, such as SQ radicals, and to provide information on 
other important parameters of biological systems.
75
  
3.2 RESULTS 
 
3.2.1 HSA Thiol-BQ Reactions 
 
Loss of thiol reactivity of DTNB was observed with both fresh HSA and DTT 
reduced HSA when they were incubated with BQ before reacting with DTNB. In order to 
confirm the thiol residue as the target for BQ, the thiol blocking reagent N-
ethylmaleimide (NEM) was incubated with DTT-reduced HSA followed by dialysis 
before addition of DTNB. Figure 3.1 shows that BQ and NEM resulted in 72.3 ± 2.6% 
and 90.4 ± 2.3% loss, respectively, of HSA thiol-DTNB reactivity after 5 min at 21:1 
molar ratios of BQ:HSA and NEM:HSA. A paired t-test of the thiol losses demonstrated 
a significant difference (p < 0.05) between BQ and NEM induced thiol loss. Dialysis of 
both the HSA-BQ and HSA-NEM adducts did not result in recovery of Cys34 reactivity, 
confirming that both BQ and NEM bind irreversibly to Cys34 on HSA. There was, 
however, a slight dilution of the protein concentration after dialysis. Preincubation of 
HSA for 30 min with BQ or NEM with subsequent DTNB reactivity assay resulted in 
85.4 ± 3.7% and 91.5 ± 4.2% thiol loss, respectively (Figure 3.1). The thiol reactivity loss 
between BQ and NEM were not statistically significant (p = 0.16) after 30 min. 
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Figure 3.1: Measurement of BQ binding to HSA Cys34 by loss of DTNB reactivity.  HSA 
was treated with DTT, dialyzed and reacted with BQ.  NEM was used as a positive 
control.   (a) 0.8 mg/mL HSA reacted with 1 mM DTNB, (b) 0.8 mg/mL HSA 
preincubated with 1 mM BQ reacted with 1 mM DTNB, (c) 0.8 mg/mL HSA preincubated 
with 1 mM NEM reacted with 1 mM DTNB, (d) 1 mM DTNB.  
 
3.2.2 BQ reactivity to Primary Amines in HSA 
 
 Trinitrobenzene sulfonic acid (TNBS) reactivity of accessible primary amines on 
non-conjugated HSA was compared to HSA that had been conjugated with BQ. There 
was 18.4 ± 2.9% loss of TNBS amine reactivity when BQ was incubated with HSA in 50 
mM (NH4)2CO3, pH 7.4 buffer.  Interestingly, BQ amine binding was enhanced to 35.6 ± 
6.6 % of TNBS reactive HSA amines when BQ conjugation was performed in PBS (pH 
(a) 
(b) 
(c) 
(d) 
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7.4). Dialysis of the HSA-BQ adduct did not result in recovery of primary amine 
reactivity confirming that BQ also binds irreversibly to primary amines on HSA. 
 
3.2.3 Serum Thiol – BQ Reactivity 
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Figure 3.2: Measurement of BQ binding to Serum thiol by loss of DTNB reactivity.  (a) 
25𝜇L plasma protein stock in 500 𝜇L reacted with 0.1 mM DTNB, (b) 25𝜇L plasma 
protein stock in 500 𝜇L preincubated with 0.1 mM BQ reacted with 0.1 mM DTNB, (c) 
25𝜇L plasma protein stock control in 500 𝜇L preincubated with 0.1 mM NEM reacted 
with 0.1 mM DTNB, (d) 25 uL Plasma protein control into 500 uL and (e) 0. 1 mM DTNB 
control into 500 uL.  
 
  The serum total sulfhydryl concentration ([SHT]) following reaction with DTNB 
for 15 min was 221 µM. Dialysis of the serum samples removed low molecular weight 
(a) 
(b) 
(c) 
(d, e) 
 And 
e) 
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thiols with resultant [SHTd] being 117 µM. For the undialysized serum BQ and NEM 
thiol loss ([SHr]/[SHT]) after 5 min was 74.4 ± 5.6 and 89.2 ± 3.7%, respectively, 
showing significant difference (p < 0.05) between BQ and NEM. Preincubation for 30 
min resulted in 90.7 ± 6.7 and 93.5 ± 5.9% thiol loss, respectively, which was not 
statistically significant (p > 0.05). Dialysis of the serum samples incubated with BQ and 
NEM resulted in reduced DTNB reactivity for the control serum sample and all other 
samples even though the post-dialysis thiol loss [SHd] per total serum thiol of the control 
post dialysis [SHTd] did not change. The thiol loss was reduced to 67.9 ± 4.7 for BQ and 
70.1 ± 3.9% for NEM 5 min preincubations. When the BQ and NEM preincubation 
period with the dialyzed serum samples was extended to 30 min the thiol losses were 76.9 
± 5.3% and 82.6 ± 7.1%, respectively (Figure 3.2). 
3.2.4 NBT-BQ/BQD Reactions 
 
 The previously reported nitrobenzenethiol assay for screening thiol reactive 
haptens
76
 was used in this study to determine the reactivity of BQD electrophilic species 
(E). The decrease in absorption of NBT at 412 nm (ε412nm = 11068 ± 126 M−1cm−1) was 
measured after rapid mixing with BQD. As an example, Figure 3.3 and Figure 3.5 show 
the consumption of NBT with MBQ and CBQ respectively.  
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Figure 3.3: Reaction of MBQ with NBT in 50% acetonitrile in a pH 7.4 phosphate buffer 
at 25 
o
C. Absorbance readings were performed at 412 nm. Using [NBT]0 = 0.1 mM BQ 
concentrations were varied from (a) 0.0 mM, (b) 0.0125 mM, (c) 0.025 mM, (d) 0.05 mM, 
(e) 0.1 mM,  (f) 0.2 mM, (g) 0.4 mM and (h) 0.8 mM.  
 
 
 
 
2D Graph 2
Time (s)
0 2 4 6 8
[N
B
T
]/
M
0
20x10-6
40x10-6
60x10-6
80x10-6
100x10-6
(a) 
(b) 
(c) 
(d) 
(e) 
(f) 
(g and h) 
 41 
 
 
 
 
Figure 3.4: Initial rate vs. [2-MBQ] for results taken from Figure 3.3. Rate constants are 
calculated from the slope of the [E] vs. initial rate for NBT depletion.  
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Figure 3.5: Reaction of 2-CBQ with NBT in 50% acetonitrile in a pH 7.4 phosphate 
buffer at 25 
o
C. Absorbance readings were performed at 412 nm. Using [NBT]0 = 0.1 
mM BQ concentrations were varied from (a) 0.0 mM, (b) 0.025 mM, (c) 0.05 mM, (d) 0.1 
mM,  (e) 0.2 mM, (f) 0.4 mM, (g) 0.8 mM, (h) 1.6 mM  and (h) 3.2 mM.  
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Figure 3.6: Initial rate vs. [2-CBQ] for results taken from Figure 3.5. Rate constants are 
calculated from the slope of the [E] vs. initial rate for NBT depletion.  
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The NBT-E reactions were measured at different time intervals from 0.1 s to 10 
min under pseudo-first order conditions ([NBT) « [E]). 
NBT0 + E0 → NBT0-E0 + NBTt                                                           (3.1) 
The absorbance of the remaining free thiol at time t, was used to calculate [NBT]t using 
the molar absorptivity of NBT. 
              [NBT0] = ( ANBTt )/(ε)                                                                         (3.2) 
Figure 3.4 and Figure 3.6 show how the apparent rate constant (k = -ka[NBT]0) and order 
of reactions with respect to electrophile were determined from the slope of the at least 
five initial rates (Ri) against five concentration variations of E for a fixed [NBT]. Linear 
plots which were obtained with all NBT- E reactions (e.g., Figure 3.4, r
2
 = 0.997) 
confirmed that the reactions were pseudo first order with respect to BQD. The order of 
reactions of BQD and the apparent rate constants (k) are listed in Table 3.2. Equation 3.3 
for initial rates, derived from Equation 3.1, was integrated to give Equation 3.4 for the 
overall reaction where k’ = ka[E]0;   
          Ri = d[NBT]/dt = -ka[NBT]0[E]0                                                           (3.3) 
        ln{[NBT] – [NBT]∞} = -k’t + ln[NBT]0                                                                           (3.4) 
The NBT depletion data for all initial concentrations of the BQD electrophiles (E) 
were fitted into the integrated rate law (Equation 3.4) and the k values given in Table 3 
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calculated for the given [E] variations for all BQD. NBT is amenable to oxidative 
reactions such as disulfide formation which can compete with NBT reactions with the 
BQD. The side reactions for NBT were minimized by varying initial [E]0 and plotting the 
slopes, (-ks[E]0), obtained from plots of data fitted into Equation 3.4 against [E]0. By 
assuming that the ki « ks within the overall reaction time, where ki  is the rate of loss of 
NBT due side reactions and ks is the rate of NBT reaction with E the Equation 3.5 is 
reduced to Equation 3.6; 
R = - d[NBT]/dt = -ka[NBT]0[E]0 +ki[NBT]                                            (3.5)      
 R = - d[NBT]/dt = -ka[NBT]0[E]0                                                           (3.6)                                       
Pseudo-first-order rate constants were calculated as the slopes of the resultant 
linear curves ([E] vs -ka[E]0 and intercept gave the pseudo-first-order rate constant ki for 
the side reaction. The rate constants ka, ks and ki, are listed in Table 3.2.  
The rate constant values for ka and ks were not significantly different for all BQD. There 
was an increase in the disulfide formation or loss of NBT for chlorine substituted BQ as 
indicated by higher ki values (ranging from 2.98 s
-1
 for CBQ to 0.387s
-1
 for 2,6-DCBQ). 
The rate constants in Tables 3.1-3.2 demonstrate that reactivity of BQ decreased 
significantly when electron donating groups were added with the observed order (CH3)3C 
< CH3 < H. The reaction half-lives (t1/2) ranged from 0.4 ms (BQ) to 0.95 s (tBBQ).  
In comparison, the rate constants for electron withdrawing substituents (EWG) 
substituents were much higher than those of electron donating substituents (EDG) at pH 
7.4. For example the rate constant for CBQ was 132 fold higher than that for MBQ and 
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that of 2,5- DCBQ was 2.5x10
6 
higher than that of DMBQ. The kinetics at pH 5.5 for 
BQD with EWG were too fast to be measured on the stopped-flow spectrophotometer. 
Table 3.1: Rate Constants Derived from the Initial Rate Methods for NBT-BQ/BQD 
Reactions. 
Chemical 
 
   k (s
-1
) 
 
   r
2
 
 
Order 
 
BQ (pH 7.4) (6.96 ± 0.02)x 10
-1
 0.996 1 
BQ (pH 5.5) 1.622 ± 1.09 0.989 1 
    
(EDG) pH 7.4    
MBQ (7.75 ± 0.03) x 10
-3
 0.994 1 
tBBQ (1.91 ± 0.08) x 10
-3
 0.991 1 
2,5-DMBQ (7.22 ± 0.24) x 10
-5
 0.994 1 
    
(EWG) pH 7.4    
CBQ 1.023 ± 0.03 0.996 1 
2,6-DCBQ (8.72 ± 5.07) x 10
1
 0.987 1 
2,5-DCBQ (1.97± 0.12) x10
2
 0.989 1 
    
(EDG) pH 5.5    
MBQ (1.31 ± 0.34) x 10
-1
 0.997 1 
tBBQ (3.32 ± 0.04) x 10
-2
 0.999 1 
2,5-DMBQ (2.30 ± 0.07) x 10
-3
 0.995 1 
 
The reactivity of BQ was enhanced significantly when the substituents were electron 
withdrawing. The order of reactivity was BQ < CBQ < 2,6-DCBQ < 2,5-DCBQ as 
demonstrated by the k values in Table 3.2 and Table 3.2.  
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Table 3.2: Rate Constants and Half Lives for BQ and BQD at pH 7.4 and 5.5. 
Chemical 
 
       k a(s
-1
)       
 
ks (s
-1
) 
 
t ½(s) 
 
ki (s
-1
) 
 
BQ (pH 7.4) 1.66 x 10
3
 (1.50  ± 0.22) x10
3
 4.44 x 10
-4
 1.06 x 10
-2
 
BQ (pH 5.5) 
 
2.61 x 10
4
 
 
(2.26 ± 0.08) x 10
4
 
 
3.07 x 10
-5
 
 
6.94 x10
-1
 
 
(EDG) pH 7.4     
MBQ 3.87 x 10
2
 (3.23 ± 0.01) x 10
2
 2.14 x 10
-3
 5.74 x 10
-3
 
tBBQ 2.39 x 10
1
 (2.31 ± 0.03) x 10
1
 3.00 x 10
-2
 8.06 x 10
-4
 
DMBQ 
 
7.47 x 10
-1
 
 
(7.27 ± 0.21) x 10
-1 
 
9.54 x 10
-1
 
 
2.93 x 10
-4
 
 
(EWG) pH 7.4     
CBQ 2.18 x 10
5
 (2.62 ± 0.01) x 10
5
 2.64 x 10
-6
 3.78 x 10
-1
 
2,6-DCBQ 1.60 x 10
6
 (1.21 ± 0.04) x 10
6
 5.74 x 10
-7
 2.98  
2,5-DCBQ 
 
2.92 x 10
6
 
 
(2.83 ± 0.09) x 10
6
 
 
2.45 x 10
-7
 2.99  x 10
-1
 
(EDG) pH 5.5     
MBQ 1.51 x 10
3
 (1.60 ± 0.07) x 10
3
 4.34 x 10
-4
 1.71 x 10
-3
 
tBBQ 3.60 x 10
2
 (3.37 ± 0.06) x 10
2
 2.06 x 10
-3
 3.33 x 10
-2
 
DMBQ 1.05 x 10
1
 (1.25 ± 0.03) x 10
1
 5.56 x 10
-2
 1.48 x 10
-3
 
 
3.2.5 Benzoquinone Derivatives and Free Radical Formation 
 
Figures 3.7(a-e) show the EPR signals that were observed with EWG substituted BQD. 
No EPR signals were observed with free DMPO and all EDG substituted BQD. The EPR 
signal intensity was in the order; 2,5-DCBQ > 2,6-DCBQ > CBQ > BQ. This trend in 
EPR intensity signal was the same trend which was observed with pseudo-first order rate 
constants. Reduction of the BQ resulted in a weak signal of approximate 1:2:1, triplet line 
spectrum (a
H2
 = a
H3
 = a
H5
 = a
H6
 = 2.4 G at pH 7.4). Under the same conditions (50 mM 
DMPO and pH 7.4) there was a 5 fold increase in SQ
. 
yield from reduced CBQ compared 
to the reduced BQ radical.  
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Figure 3.7: Effects of chlorine substitution on BQ on EPR signal intensity for (a) 
DMPO,(b) BQ (c) CBQ, (d) 2,6-DCBQ and (e) 2,5-DCBQ in 50 mM phosphate buffer, 
100 mM DMPO and 50 µM of the corresponding BQD at 25
 o
C. 
This demonstrated that the chlorine substituent has an effect on SQ radical yield. CBQ 
reduction gave a quartet of lines, with a peak height ratio of 1:3:3:1 and hyperfine 
splitting of a
H3
 = 2.2 G, a
H5
 = 2.4 G and a
H6
 = 2.3 G as shown in Figure 3.7.  
The addition of another chlorine atom (2,6-DCBQ) resulted in a 3 fold increase in 
signal intensity of the corresponding SQ radical compared to the EPR signal from CBQ. 
2,6-DCBQ gave the expected triplet line spectrum (1:2:1), a
H3
 = a
H5
 = 2.5 G. There was 
an observed 1.3 fold increase in the signal intensity signifying an increase in stabilization 
effect when the second chlorine was put on the 5
th
 position of the ring to form 2,5-
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DCBQ. A triplet line spectrum (1:2:1) was also observed with 2,5-DCBQ, with a
H3
 = a
H6
 
= 2.2 G. 
There was an observed shift in peaks to higher magnetic field and g-value 
whenever a chlorine atom was added or changed positions on the BQ and the same trend 
of increase (depending on number and position of chlorine atom) was observed on EPR 
signal intensity (Table 3.3.  
Table 3.3: Summary of Peak shift and g-factor Values. 
Chemical  Peak shift (mT) g-factor 
   
BQ 0 (Standard) 2.001382 
CBQ 0.0782 2.001534 
2,6-DCBQ  0.176 2.001585 
2,5-DCBQ 0.215 2.002077 
 
3.2.6 The Effect of pH on Radical formation 
 
The determination of the effect of pH on radical formation was done using 
phosphate buffer from pH 5.5 to pH 8.6. Using 2,6-DCBQ as an example, Figure 3.8 
shows that there was no EPR signal detected when pH was below 6.5. The increase in pH 
from 6.5 introduces more OH
- 
 ions into the system which act as a reducing agent to 
quinones giving semiquinone radicals.
77
 The peak signal intensity went up from pH 6.5 to 
7.6 and then down after pH 7.6. 
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Figure 3.8: The relationship between EPR signal intensity and rate constants due to pH 
variation for [2,6-DCBQ]0 = 50 µM in 50 mM of phosphate buffer and 100 mM DMPO 
at 25
 o
C. (a) EPR signal due to DMPO-SQ adduct formation (b) EPR signal due to 
DMPO-OH and trace (c) shows the effect of pH on the rate of reaction between 2,6-
DCBQ and NBT. There is an inverse relationship between the rate constant and EPR 
DMPO-SQ signal. 
 
Under the aerobic conditions of these experiments the oxygen acts as a fast and 
efficient radical quencher whilst forming a superoxide or peroxy radical (ROO
.
).
77
 The 
decrease in signal intensity peak after pH 7.4 is attributed to the peroxy radicals which 
are reported to form from dissolved oxygen
78
 The spectrum was composed of a quartet of 
lines, with a peak height ratio of 1:2:2:1, with parameters including hyperfine constants, 
a
H
 = 14.8 G and was attributed to the DMPO-OH. These parameters are typical of a 
DMPO-OH adduct EPR signal generated by the reaction of OH with DMPO.
79
 The peaks 
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at pHs > 7.6 increased in intensity then went down as the DMPO-OH
 
adduct peaks 
appeared and increased in intensity.  A proposed scheme leading to DMPO-OH 
formation is shown in Figure 3.9. The electron g-factors of BQD radicals changed with 
increasing number of chlorine atoms and position(s) of the chlorine substituents on the 
BQ ring (Table 3.3). Compared to BQ radical (g = 2.001382) the CBQ (g = 2.001534, Δg 
= 0.000152) and the 2,6-DCBQ (g = 2.001585, Δg = 0.000203) and changing chlorine 
position to 2,5-DCBQ (2.002077, Δg = 0.000695). This increase in g-value was 
harmonious with the increased spin orbit coupling that is expected with increasing 
number of chlorine atoms. 
 
   
Figure 3.9: Schematic routes which lead to DMPO-SQ and DMPO-OH EPR active 
adduct formation. 
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3.2.7 EPR Spectrum Simulations  
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Figure 3.10: Computer simulations on the effects of chlorine substitution on BQ on EPR 
signal intensity data shown in Figure 5(c) CBQ and (d) 2,6-DCBQ. This model gave a 
reasonably good fit to the experimental data in both hyperfine splitting constants and the 
signal intensity. 
The main objective with respect to spectrum simulations was to obtain a 
satisfactory simulation of the room-temperature EPR spectrum for BQ with EWG using 
CBQ and 2,6-DCBQ as examples (see Figure 3.10). The fitting of the data were simple 
and the best fit values were obtained with hyperfine splitting constant, a
H3
 = a
H5
 = 2.5 G 
for 2,6-DCBQ and a
H3
 = 2.2 G, a
H5
 = 2.4 G and a
H6
 = 2.3 G for CBQ. The adopted values 
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for hyperfine splitting constant are most likely valid for the BQD radical formation at 
physiological pH. 
 
3.2.8 NBT Effect on SQ Radical Formation 
 
  Figure 3.11 shows that the addition of NBT to a DMPO and 2,6-DCBQ mixture 
decreased the amount of EPR signal formed even when the DMPO was in excess over 
both the NBT and the 2,6-DCBQ. Control experiments showed no reactivity between 
DMPO and NBT. Figure 3.9 shows that mixing NBT and 2,6-DCBQ in equimolar 
quantities resulted in about 50% loss of EPR signal. When NBT was 3-fold in excess 
over 2,6-DCBQ the EPR signal loss was > 90% in agreement with the NBT-2,6-DCBQ 
reactivity that was observed. The loss of EPR signal is due to NBT-BQ adduct formation 
overpowering the production of DMPO-SQ adduct formation. This shows that the rate of 
production of free radicals from 2,6-DCBQ is much slower than the rate of adduct 
formation between NBT and the 2,6-DCBQ. The NBT quenches the system of any 
available 2,6-DCBQ thus no radicals are produced. This suggests that the free radical 
mechanism is overshadowed by the MA and therefore has minimal contribution to the 
rate constants obtained for the rapid depletion of NBT. 
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Figure 3.11: Plot of depletion of DMPO-SQ signal versus [NBT] at 25 
o
C. [DMPO]0 
=100 mM, [2,6- DCBQ]0 = 0.05 mM, and  varied [NBT]= (a) 0 mM, (b) 0.02 mM, (c) 
0.04 mM, (d) 0.08 mM, (e) 0.16 mM, (f) 0.32 mM  and 0.6 mM in 100 mM phosphate 
buffer of pH 7.4. 
 
3.3 DISCUSSION 
 
Murine local lymph node (LLNA) studies rank BQ as an extreme dermal 
sensitizer with an EC3 (threshold) value of 0.013%.
80
 BQ covalent binding to proteins 
resulting in immunogenic complexes has been attributed to BQ’s reactivity as a Michael 
acceptor. New evidence
81,82
 on both the quinone’s unique electrophilic chemistry and 
high reactivity, however, provides alternative hypothesis on the possible contributory role 
of other reaction pathways to BQ’s overall reactivity towards nucleophiles such as 
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cysteinyl amino acids on proteins.
83
 The impact of substituents on BQ’s reactivity and 
ultimate in vivo allergenicity had not been previously assessed. 
 Binding experiments with HSA demonstrated that Cys34 (the only reduced thiol 
in HSA) on the protein is the preferred target for BQ binding and the bond formed is an 
irreversible covalent bond. BQ was shown to have high affinity for thiols when serum 
was used as the source for thiols. Comparison of BQ and NEM blocked thiols pre- and 
post-dialysis showed that the ratios [SHr]/[SHT] and [SHd]/[SHTd] were equal 
demonstrating the binding of BQ to both high and low molecular weight thiols such as 
cysteine and glutathione. The binding of BQ to cysteine and glutathione may result in 
reduced BQ available for protein binding, but its extreme potency
80
 in the LLNA assay 
shows that the concentrations absorbed through the skin during the in vivo assay are high 
enough to overcome any clearance which may result from low molecular weight thiol 
binding. The observed 85.5 % loss of reactivity to thiols compared to 18 % loss of 
reactivity to primary amines under identical conjugation conditions, demonstrates that 
BQ is much more reactive to thiols than amines, in agreement with previously reported 
observations.
84
 
 The thiol nucleophile, NBT, was used to measure reactivity of six BQD. NBT has 
previously been utilized as a model nucleophile where relative reactivity of electrophilic 
allergens to NBT was highly correlated to LLNA EC3 values.
76
 All the BQD tested 
rapidly reacted with NBT. There was, however, a 90 fold decrease in reactivity of the BQ 
ring when MBQ was reacted with NBT. The methyl group donates electrons into the BQ 
π system leading to an increase in electron density on the π system with consequent 
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reduction of the partial positive charges on the electrophilic carbons on BQ. The π 
electrons also repelled the electrons on the –SH group on NBT thus slowing down the 
reaction. The positive inductive effect became more apparent when the methyl group was 
replaced with the tert-butyl group. The reaction dropped by approximately 4 fold from 
MBQ to tBBQ. This was due to more electron donating ability of tert-butyl compared to 
methyl group. The steric hindrance offered by tert-butyl, to the incoming NBT, compared 
to the methyl group could also have contributed the decreased reactivity of tBBQ. For 
NBT-DMBQ reactions, the further 26-fold loss of reactivity relative to tBBQ can be 
attributed to the increased positive inductive effect of two methyl groups in close 
proximity to the reacting β carbocations. The repulsive force of π electron cloud around 
the electrophilic carbon was increased by having two methyl groups on the ring.  
 For activated BQD the pseudo-first order rate constants for NBT reactivity at pH 
7.4 increased in the following order BQ < CBQ < 2,6-DCBQ < 2,5-DCBQ (Table 3.2). 
The effect of the increased negative inductive effect on the rate constants is apparent 
from CBQ to the dichloro-substituted BQD. When 2,6-DCBQ was reacted with NBT 
there was an 85-fold increase in NBT reactivity compared to CBQ. There was an 
observed increase in rate constants by 2 fold between 2,6-DCBQ and 2,5-DCBQ with the 
latter being faster. The difference in reactivity between the dichloro substituted 
derivatives may be attributed to the fact the 2,5-DCBQ has its chlorine atoms in para 
positions to each other which makes the carbon atoms on which the chlorine atoms are 
attached more partially positive due to inductive withdrawal of electrons, unlike the 2,6-
DCBQ which has chlorine atoms on meta positions to each other and do not influence 
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each other by inductive electron withdrawal. This makes 2,5-DCBQ more reactive than 
2,6-DCBQ. This strongly agrees with the findings of Enoch et al. 
85
 in which a direct 
relationship between electrophilic effects of a chemical and rate reaction by Michael 
addition reaction were observed  and used in an electrophilicity index for prediction of 
skin sensitization potential. For both 2,6-DCBQ and 2,5-DCBQ, the –SH on NBT adds 
on to position on which the chlorine atom is attached  by MA and then nucleophilic 
elimination of the chlorine atoms (reaction of 1
st
 mole on Scheme 4.3). 
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The structure for 2,5-DCBQ is such that it will undergo MA and then nucleophilic 
substitution onto position 2 and 5 which have the higher electrophilicity. 2,6-DCBQ 
where positions 2 and 6 are not influenced by the negative inductive effect of the chlorine 
atoms possess a lesser partial positive charge on these positions This makes 2,5-DCBQ 
more reactive than 2,6-DCBQ. Increased rate constants increased several-fold for MBQ, 
DMBQ and tBBQ when NBT reactivity was measured at pH 5.5 suggesting that the MA 
reactions are acid catalyzed, Figure 3:6 shows an inverse relationship between rate 
constant and pH. The acid catalysis is more pronounced for CBQ, 2,5-DCBQ and 2,6-
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DCBQ reactions performed at pH 5.5 which could not be measured using the stopped 
flow technique. The fact that rate constants for MBQ, DMBQ and tBBQ had increased 
several-fold under pH 5.5 but were still lower than those of CBQ, 2,5-DCBQ and 2,6-
DCBQ at pH 7.4 demonstrates the agreement on the effect of electron donating versus 
electron withdrawing substituents on BQ reactivity under pH’s 7.4 and 5.5. 
BQ has been hypothesized to haptenate proteins via MA. The production of 
semiquinone (SQ) radicals as a mechanism of BQD protein haptenation was investigated 
and EPR signal intensity was of the order; 2,5-DCBQ > 2,6-DCBQ > CBQ > BQ. No 
EPR signals were observed with methyl- and tert-butyl-substituted BQD. BQ generated 
radicals are known to form through the one electron reduction of BQ, followed by 
hemolytic cleavage of the O-O bonds on the carbonyl functional group. The resulting SQ 
radical may potentially bind directly to a protein.
86
 Thus the presence of the SQ radical 
indicated the potential of free radical mechanisms as another mechanism of BQD 
covalent modification of proteins. Increased production of free radicals from chloro-
substituted BQD (Figure 3.7) is a result of the high negative inductive effect arising from 
the highly electronegative chlorines. This activates the BQ in contrast to the positive 
inductive effect of the electron donating groups. The increase in g-values from the mono-
chloro-substituted to the dichloro-substituted BQD is harmonious with the increased spin 
orbit coupling that was expected with increasing number of chlorine atoms. Halogenation 
of BQ has been known to increase the persistence of SQ radicals.
87
 The EPR results show 
that the yield of the SQ radicals resulting from chlorine substituted BQD depend on pH 
and on the position and number of chlorines on the SQ ring.  
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The trend in EPR intensity signal agreed with the observed order of reactivity 
indicating that inductive effects have a dominant influence on the chemistry of the BQD 
compared with other factors such as steric hindrance. The effect of pH on radical 
formation (Figure 3.8) highlights the sensitivity of the SQ radicals to either acidic or 
basic conditions. The increase in pH from 6.5 to 7.6 might have introduced more OH
- 
 
ions into the system which act as a reducing agent to quinones giving semiquinone 
radicals.
77
 Beyond pH 7.6 the OH
-
 effect might have been overcome by the presence of 
produced oxygen which has been reported to act as a fast and efficient SQ radical 
quencher, forming a superoxide radical or peroxy radical (ROO
.
)
77
 in the process (Figure 
3.9). Peroxy radicals have been shown to produce dissolved oxygen in alkaline conditions 
thus availing more oxygen which quenches the SQ radical. The observed decrease in SQ 
radical peaks intensity at pH > 7.6 (Figure 3.8) as the peaks of DMPO-OH
 
adduct 
simultaneously started appearing can explain the minimum or no role of OH
-
 and oxygen 
quenching in the temporary increase in SQ radical intensity at pHs 7.6 and below 
followed by oxygen quenching at pHs beyond 7.6.  
 The contribution of a free radical pathway to protein haptenation may not be 
significant because of lack of production of SQ radicals at acidic pH, in contrast with the 
increased NBT reactivity which was observed at pH 5.5. Skin pH is around 5.5 and lack 
of formation of radicals shown herein means that BQ and BQD binding to proteins will 
occur via MA with additional vinylic substitution where the substituents such as chlorine 
are good leaving groups. The dominance MA versus free radical formation was also 
demonstrated with the inclusion of NBT to (DMPO + BQ) mixture (pH 7.4) which 
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resulted in quenching of the EPR signal even when the DMPO >> NBT and the BQD. 
The loss of EPR signal was due to NBT-BQ adduct formation (Figure 3.11) which 
formed at rate that was faster than the production of DMPO-SQ adduct formation. It may 
have been possible that NBT quenching of the EPR signal was due to the SQ radical 
forming quickly and then reacting with NBT to form an EPR silent adduct. This 
argument was, however, dismissed when MS and NMR characterization of adducts 
formed in the reaction mixture showed no presence of NBT-SQ adducts. NBT mops the 
system of any available BQD thus no radicals are produced. This aspect proves that the 
free radical mechanism plays a minimal role, at best, in BQD binding. The dominance of 
MA as a pathway is further supported by quantitative mechanistic read-across based 
estimation of BQ EC3 values which utilized known potency data for sensitizers in the 
MA domain. A theoretical EC3 value of 0.013% was obtained in agreement with actual 
LLNA EC3 value of 0.01%.
80
 
 The inclusion of substituents on BQ has been shown to have a profound effect on 
the overall chemistry of BQ. This is manifested in an increased or decreased reactivity of 
BQD toward NBT and the emergence of other mechanistic pathways such as free radical 
mechanism and vinylic substitution. From the hapten hypothesis
88
 perspective the effect 
of vinylic substitution for the chloro-substituted BQD would not lead to any 
immunogenic adducts that are different from those formed with BQ as this step is 
subsequent to MA which results in adduct formation. The substituted chlorine leaves as a 
salt which would not be expected to modify any proteins. 
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3.4 CONCLUSION 
 
It can be concluded that the order of reactivity of BQD to NBT was 2,5-DMBQ < 
tBBQ < 2-MBQ < BQ < CBQ < 2,6-DCBQ < 2,5-DCBQ as demonstrated by the k 
values. MA is the dominant mechanism for BQ and methyl-BQD haptenation of proteins 
and that MA followed by vinylic substitution is dominant for chlorine-BQD. Based on 
the findings in these studies SQ radical induced binding of proteins may play a minimal 
to no role in the development of BQD sensitization. 
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                                         CHAPTER FOUR 
 
CHARACTERISATION OF ADDUCTS AND REACTION 
MECHANISMS 
 
4.1 INTRODUCTION 
 
Chemically induced modification of proteins by natural toxins and synthetic 
toxicants can alter protein function, disrupt signal transduction, and interfere with 
subcellular protein localization. This section gives an outline of the reaction mechanisms 
between BQD and NBT   as well as identifying the corresponding adducts formed in the 
process. Chemical characterization is important to determine whether conjugation has 
been achieved and to quantitate the ratio of chemical ligands bound per molecule of 
carrier protein. Conjugate addition of one molecule of various sulfur nucleophiles to p-
benzoquinones is well known. However, double conjugate additions of sulfur 
nucleophiles to p-benzoquinones are rare and only one such example was found in the 
literature.
14
 
The BQD-NBT products formed in phosphate buffer (pH 7.4) were characterized. 
All reactions and products were separated using reversed-phase liquid chromatography 
(LC) with ultraviolet absorbance (UV), and mass spectrometric (MS) detection. It was 
very important that only reagent grade chemicals with a high degree of purity be used for 
the preparation of samples. The section serves to determine the stoichiometric binding 
ratio between NBT and BQD, identification of adducts formed and relative abundance of 
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reaction products observed using ESI-MS and identify the specific binding site(s) of NBT 
on BQD using 
1
HNMR.  
 
4.2 RESULTS AND DISCUSION 
 
2-((4-nitrophenyl) thiol) benzene-1, 4-diol(2a and 5a), was a product of both 
BQ and CBQ reaction with NBT. 2a was recovered by solvent extraction using n-hexane 
which was evaporated using a rotor evaporator.
 1
H NMR(CDCl3, 400 MHz) δ 8.10 (d, J = 
9.0 Hz, 2H), 7.14 (d, J = 9.0 Hz, 2H), 7.05 – 6.94 (m,3H). ESI-MS exact mass calculated 
for [M–H]- requires m/z 262.01795, found 262.01779 2a and 262.01746 for 5a and ESI-
MS data was recorded using a scan range of m/z 100-600.  
2-methyl-6-((4-nitrophenyl)thio)benzene-1,4-diol (3a) was a produced as 
yellow crystals from the reaction of MBQ with NBT. The reaction mixture was purified 
by preparative TLC with the eluent ethyl acetate/n-hexane (1.5:8.5 ratio). 
1
H NMR 
(CDCl3, 400 MHz) δ (ppm) 8.32 (d, J = 8.9 Hz, 9H), 7.71 (d, J = 8.9 Hz, 11H), 6.56 (s, 
1H), 5.90 (s, 2H), 2.12 (s, 7H). For MS analysis ESI-MS solvent was 50:50 water: 
methanol which resulted in the m/z 276.03259, against the exact mass m/z = 276.03360 
calculated for [M–H]-. 
2,5-bis((4-nitrophenyl)thio)benzene-1,4-diol (7a), The reaction mixture was 
purified by preparative TLC, eluent ethyl acetate/n-hexane (1:9 ratio) and orange crystals 
were obtained. 
1
H NMR (CDCl3, 400 MHz) δ (ppm) 8.13 (d, J = 9.1 Hz, 2H), 7.30 (s, 
1H), 7.17 (d, J = 9.1 Hz, 2H). 
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2,5-dimethyl-3-((4-nitrophenyl)thio)benzene-1,4-diol (8), Flash 
chromatography eluent, n-hexane =100% with reaction time of 1 min, then ethyl 
acetate/n-hexane = 1:1 for 12 min. Fine yellow crystals after drying the solvent on a rotor 
vapor. 
1
H NMR (CDCl3, 400 MHz) δ (ppm) 8.08 (d, J = 8.7 Hz, 2H), 7.09 (d, J = 8.7 Hz, 
2H), 6.82 (s, 1H), 4.77 (s, 2H), 2.35 – 2.15 (m, 6H). 13C NMR (CDCl3, 100 MHz) δ 
(ppm) 125.76 (d, J = 7.3 Hz), 124.30, 121.14, 77.34, 16.39, 13.79.  
 
4.2.1 Characterization of BQD-NBT Adducts 
 
Based on NMR and MS characterization of the NBT-BQD reaction products, 
NBT was shown to react with BQ 2 to give a 1:1 ratio product 2-((4-nitrophenyl) thiol) 
benzene-1, 4-diol 2a in phosphate buffer at pH 5.5 after 1 h. The electron-donating group 
substituted benzoquinones reacted through MA (Scheme 4.2) giving a 1:1 ratio with 
NBT; MBQ 3 gave 2-methyl-6-((4-nitrophenyl)thio)benzene-1,4-diol 3a, tBBQ 4 gave 2-
(tert-butyl)-6-((4-nitrophenyl)thio)benzene-1,4-diol 4a and DMBQ 8 gave 2,5-dimethyl-
3-((4-nitrophenyl)thio)benzene-1,4-diol 8a. The reaction between CBQ 5 and NBT was 
involved two reaction mechanisms in the following order; MA reaction followed by 
vinylic substitution (Scheme 4.3). Reaction between NBT and CBQ gave 2 products as 
confirmed by ESI-MS (Figure 4.1); a monosubstituted benzoquinone, 2-((4-
nitrophenyl)thio)benzene-1,4-diol 5a, and disubstituted benzoquinone; 2,6-bis((4-
nitrophenyl)thio)benzene-1,4-diol 5b. The reaction between the di-substituted chloro-
benzoquinones 2,5-DCBQ and 2,6-DCBQ gave corresponding di-substituted 
benzoquinone with chlorines being substituted by NBT in 1:2 ratios (BQD:NBT).  
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Figure 4.1: Negative ESI-MS spectra of p-nitrobenzenethiol adduct(s) formation with 
CBQ giving a mono-NBT-hydroxyl BQ adduct (m/z 415.00540) and a di-NBT-hydroxyl 
BQ adduct (m/z 262.01746) and spectrum. 
 
Reaction between 2,5-DCBQ 6 and NBT gave 2,5-bis((4-nitrophenyl)thio)benzene-1,4-
diol 6a whilst  2,6-DCBQ 7 gave a corresponding di-substituted benzoquinone ,2, 5-
bis((4-nitrophenyl)thio)benzene-1,4-diol 7a. 
The BQD-NBT reaction is acid catalyzed as shown by the faster reaction rate at 
lower pH. Acid facilitated the creation of a carbocation center on which the nucleophile 
attacks (Schemes 4.2 and 4.3). The reactions between electron donating substituted 
benzoquinone and NBT were direct 1:1 ratio MA reactions (Scheme 4.2). 
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Scheme 4.1: Reaction mechanisms for electron withdrawing and electron donating 
substituted benzoquinones with NBT  
 
NBT went onto position 6 for mono-substituted BQ and position 3 for di-
substituted BQ (Scheme 4.1), and this was confirmed by ESI-MS (Figure 4.2).  
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Figure 4.2: Negative ESI-MS spectra of p-nitrobenzenethiol adduct(s) formation with 
MBQ giving a mono-NBT-hydroxyl MBQ adduct (m/z 276.03259).  
 
For electron withdrawing substituted benzoquinones, the carbocation center 
created on the carbon on which chlorine atom was attached and this was the target for the 
–SH group on NBT followed by the substitution of the chlorine atom. In contrast to the 
methyl and tert-butyl substituted BQ the mechanism for the chlorine substituted BQs the 
reaction mechanism was direct nucleophilic vinylic substitution (SNV) with subsequent 
Michael addition (MA) reaction. As a result of the electron withdrawing substituents 
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CBQ gave 2-((4-nitrophenyl)thio)benzene-1,4-diol 5a as a product and 2,5-DCBQ gave 
2, 5-bis((4-nitrophenyl)thio)benzene-1,4-diol 7a. 
4.2.2 Reaction Mechanisms 
  
Scheme 4.2: The proposed MA reaction between MBQ and p-nitrobenzenethiol  
 
 
Scheme 4.3: The proposed reaction between CBQ and p-nitrobenzenethiol  
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4.3 CONCLUSION 
 
It can be concluded that EDG BQD (e.g. 2-MBQ) react with thiols by MA 
mechanism whilst EWG BQD haptenate to thiol proteins by vinylic substitution. These 
studies show that mono-substituted CBQ covalently binds to NBT to give 2 adducts (a 
mono-substituted BQ and a disubstituted BQ), while DCBQ give out 1 major adduct (1:2 
ration BQ: thiol). NMR results also demonstrate the variations in the stoichiometry of the 
NBT-BQD reactions as well as the shifting of positions for nucleophilic addition. 
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CHAPTER FIVE 
 
LOCAL LYMPH NODE ASSAY AND QUALITATIVE 
MECHANISTIC MODELS 
 
5.1 INTRODUCTION 
 
Existing animal based assays such as the murine local lymph node assay 
(LLNA),
89
 which is based on the proliferation of lymph node cells in the induction phase 
or the MEST
30
 and Guinea Pig Maximization Test (GPMT)
90
 which are based on the 
observation of the allergic responses in the elicitation phase of ACD are widely used to 
screen for allergenic chemicals. Mandated reduction/elimination of animals used in 
cosmetics testing in Europe has led to an increased need for alternatives to animal testing 
in the prediction of skin sensitization potential.
91 Published datasets consisting of 
quantitative reactivity test results for compounds tested in the LLNA are being used to 
develop and evaluate (validating or invalidating) alternative approaches.
92
 Hundreds of 
chemicals belonging to different mechanistic domains have been shown to possess the 
ability to induce skin sensitization. Of these, BQ is an extreme skin sensitizer (EC3 = 
0.013)
93
 which has been well recognized over the years. The effect of inserting 
substituents on the BQ ring has not been studied in animal assays.  
5.1.1 Local Lymph Node Assay 
 
 The EC3 for BQ has been published by Roberts et al.
56
 Since this EC3 for BQ 
was calculated from BQ doses that resulted in SI values that were all >> SI = 3, the 
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accuracy of the EC3 was overestimated. This study performed a preliminary LLNA to 
establish a measured EC3 for BQ that was subsequently adopted and informed the BQ 
dose to be used as a positive control for all other LLNA experiments with BQD. A wide 
range of doses was used ensuring that one dose is below the predicted EC3 and two doses 
are above those predicted to be greater than 10-fold (over vehicle) lymph node cell 
proliferation (Figure 5.1 and Figure 5.2). 
 
 
After performing the LLNA for the BQD as outlined above dose response curves were 
utilized to calculate EC3 values for all BQD tested. Comparison of predicted EC3 values 
with reactivity data was performed to test the predictive power of the reactivity assay. 
The following criteria (Table 5.1) adopted from the European Center for Ecotoxicology 
and Toxicology of Chemicals (ECETOC)
94
 was be used for potency classes:   
Table 5.1: Potency rating of skin sensitizers 
 
Potency Rating Concentration Threshold 
(EC3; %) 
Extreme <0.1 
Strong >0.1 - <1.0 
Moderate >1.0 - <10 
Weak >10 
Non-sensitizer >100 
  
 
 
 In the present study, allergenic potency of BQ and BQD were assessed in the LLNA to 
test the predictive power of previously reported reactivity data
95
 on skin sensitization. To 
check if the effect of substituents on the concentration required producing a threshold 
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positive response, the candidate chemicals were placed into the categories in Table 2.5 
based on their reaction chemistry and LLNA potency. The 7 test chemicals which make 
the basis of this study with expected sites of nucleophilic attack on the ring are shown in 
Figure 5.2. 
 
The reported
95
 reactivity constants(ka) were used to predict the LLNA EC3 values  
for the BQD. LLNA studies were then performed for BQ and BQD to determine the 
actual EC3 values and test the predictive power of the reactivity data as a way of 
validating the potential utility of the reactivity approach as an alternative method for skin 
sensitization testing. In this article, we also present skin sensitization quantitative 
structure-activity relationships (QSARs) analysis for the Michael addition (MA) and 
nucleophilic vinylic substitution (SVN) mechanistic applicability domains, in which 
BQD possess either X or Y substituents (X and Y) on different positions. 
5.2 RESULTS 
 
5.2.1 LLNA: Allegenicity Assessment 
 
 The LLNA was performed for BQ to derive a more accurate EC3 estimate rather 
than use the literature EC3 value for BQ which was exptrapolated from doses that 
produced high stimulation indexes (SI) well above three fold threshold. Figures 5.1 and 
5.2 show the doses of each BQD and the stimulation indexes. The LLNA EC3 values 
derived from these SI values using linear interpolation provided in the Figure 5.3. BQ and 
chlorine substituted BQ allergenic potency increased in the following order:  BQ (EC3 = 
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0.043 %) < CBQ (EC3 = 0.039) < 2,6-DCBQ (EC3 = 0.028 %) < 2,5-DCBQ (EC3 = 
0.013%) in agreement with the trend predicted by rate constants (listed in Table 5.2). 
Methyl substituted BQ EC3 values which ranged from < 0.1% to 0.238 % were higher 
than those of chloro BQD. The predicted LLNA by reactivity of 2-MBQ and 2,5-DMBQ 
were different, with the EC3 of  2,5-DMBQ being 18 fold higher than the EC3 value of 
2-MBQ.  The actual EC3 values of 2-MBQ and 2,5-DMBQ from the LLNA were very 
similar to each other, but in the reverse order than predicted. However, Figure 5.2 
demonstrate that 10% 2-MBQ produced a significantly higher SI than 10% 2,5-DMBQ 
(SI = 31.7% vs. 11.5%, respectively) suggesting that it may actually be a more potent 
allergen than 2,5-DMBQ as predicted from the reactivity data. The difference in the mean 
SI values of 2-MBQ and 2,5-DMBQ is greater than would be expected by chance; there 
is a statistically significant difference between the input test chemicals (P  <0.001).  
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Figure 5.1: Murine local lymph node assay (LLNA) for BQ and its derivatives (a): BQ, 
2-CBQ, 2,5-DCBQ and 2,6-DCBQ, 
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Figure 5.2:Murine local lymph node assay (LLNA) for BQ and its derivatives :2-MBQ, 
2,6-DMBQ and tBBQ  produced clinical signs of systemic toxicity including weight loss, 
lethargy and ruffled fur that gave poor dose-dependent proliferative responses and 
preventing a reliable EC3 determination. 
 
 2-tBBQ EC3 could not be estimated using the LLNA due to systemic toxicity 
observed and lack of dose-dependency of the lymph node cell proliferation in dosed 
mice. In general, the predictive equation of Chipinda et al.
57
 that was generated from data 
for multiple structurally diverse chemicals in the MA domain consistently overestimated 
                                         Dose (%)
AOO 2-MBQ 2,5-DMBQ 2-tBBQ BQ
S
ti
m
u
la
ti
o
n
 I
n
d
e
x
0
10
20
30
40
0
.0
1
0
0
.1
0
0
1
.0
0
1
0
.0
0
0
.1
0
0
0
.5
0
0
1
.0
0
0
1
0
.0
0
0
.1
0
0
0
.5
0
0
1
.0
0
0
1
0
.0
0
0
.5
0
0
 76 
 
the potency of the BQD series.  
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Figure 5.3: Stimulation index against concentration of CBQ. 
 
 Figure 5.3 is a dose response curve for shows the same results as Figure 5.1 for 
CBQ results. The vehicle used to dissolve or suspend the test agent can influence the 
results of the LLNA.  When acetone olive oil (AOO; 4:1; v/v) was used as the vehicle, 
3
H-thymidine incorporation into proliferating mouse lymph node cells resulted in the 
proliferative response shown in Figure 5.1 and 5.1 for BQD. There was a direct 
relationship between SI and the concentrations of BQD. From this graph equation of the 
y = 1.5 + 38.3x -21.3x
2
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graph was used to calculate the LLNA EC3 values which are listed on test compounds 
listed in Table 5.2. 
5.2.2 Correlation Analysis of Reactivity Data with LLNA EC3 Values 
 
 The pEC3 values for the test chemicals listed in Table 5.2 were plotted against 
      values to determine the relationship of the reactivity to the chemicals’ potency as 
skin sensitizers. A plot of pEC3 values for 6 test chemicals is shown in Figure 2.5. 
Figure 5.4: Plot of pEC 3 vs log ka of the 6 test chemicals in the Michael addition and 
nucleophilic vinylic substitution reactivity domains. pEC3 was estimated using the LLNA 
and log ka derived from reactivity toward NBT as previously reported.
20
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A strong positive correlation (R
2
 = 0.74) between potency in LLNA and reactivity was 
observed as indicated by the following linear equation (with statistical parameters); 
                          pEC3 = 0.20(± 0.05) log(ka) + 0.17(± .033)      (5.1) 
                              n = 6, R
2
 = 0.74, R
2
adj = 0.68, s = 0.27 and F = 11.6  
 
5.2.4 NBT-BQ/BQD Reactions 
 
Table 5.2: Predicted EC3 Values from Reactivity Data 
Chemical Mwt 
(g/mol) 
ka (s
-1
) Predicted 
pEC3 
LLNA 
derived 
pEC3 
 
Log P 
2,5-DCBQ 176.98 2.92 x 10
6
 7.37 4.13 1.34 
2-CBQ  142.5 2.17 x 10
5
 6.45 3.56 0.98 
2,6-DCBQ  176.98 1.60 x 10
6
 7.16 3.80 1.34 
BQ 108.1 1.66 x 10
3
 4.74 3.40 0.50 
2-MBQ  122.1 1.51 x 10
3
 4.23 2.71 0.75 
2-tBBQ  164.2 3.60 x 10
2
 3.25 ----  1.20 
2,5-DMBQ  136.2 1.05 x 10
1
 2.03 2.88 1.07 
 
1
Estimations of EC3 were performed using the regression equation pEC3 = 0.81log ka + 
2.13 as reported by Chipinda et. al (2010.) where pEC3 = log (Mwt/EC3).  
It must be stated that due to the limited number of the test chemicals used in this study 
conclusions concerning the potential relationship between chemical reactivity and 
allergenic potency cannot be made from these results. R
2
 of 0.74 between the overlapping 
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data of MA and SVN domains suggests that reactivity rate has greater influence than 
chemical mechanistic domain toward a chemical’s allergenic potency.   
  Reaction rate constants of BQ and BQD toward NBT that were previously 
determined,
95
 along with predicted EC3 values derived from equations reported by 
Chipinda et al.
21
 correlating electrophilic allergen reactivity to NBT (ka(s
-1
)) to pEC3 are 
shown in Table 5.2. There was no observable relationship between solubility (log P) and 
EC3 predicted by chemical reactivity across the entire set of test chemicals. 
5.2.5 Prediction of EC3 Values from Reactivity Data 
 
 The ka values taken from Table 5.2 were used to predict EC3 values using linear 
equation 5.2 which was derived by Chipinda et. al.
57
 utilizing a structurally diverse MA 
domain data set where pEC3 is obtained by dividing the molecular weight (Mwt) of the 
chemical by EC3 value and calculating the log. The results were compared with EC3 
values obtained from the LLNA performed for these BQD.  
            pEC3 = 0.81 log(ka) + 2.13                                                                       (5.2) 
            pEC3 = log ((Mwt/EC3))                                                                          (5.3) 
From the predicted EC3 values it was observed that the presence of the EDG on the BQ 
reduces the LLNA potency of BQ (EC3; 0.002%) from an extreme sensitizer to a strong 
sensitizer (2,5-DMBQ; EC3 = 1.28%). EWG were observed to increase the potency 
rating of BQ by reducing the threshold that is needed to cause skin sensitization as shown 
in Table 5.2.  
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5.2.6 Quantitative Mechanistic Modeling (QMM) 
 
Hammett and Taft substituent constants were taken from Perrin et al.
96
  The 
Hammett and Taft substituents and their constants are listed in Table 5.2, whilst the 
structures of test compounds are given in Figure 5.2. The reaction sites are indicated by 
the arrows.  
Table 5.3: Substituent Constants, σ- and σ* Used to Calculate Values in Table 5.3 
Chemical Hammett Constant 
 (σ-) 
Taft Constant 
(σ*) 
Reference 
p-Cl 0.24 2.96 
96
 
m-Cl 0.37 2.96 
96
 
o-Cl 0.68 2.96 
96
 
H 0 0.49 
96
 
p-CH3 -0.14 0.00 
96
 
 m-CH3 -0.06 0.00 
96
 
o-CH3 -0.13 0.00 
96
 
 
The calculated Hammett constants (∑σ-), for test compounds 2, 3, 5, 6 and 7 were 
used whilst the calculated Taft constants (σ*) for test compounds 1, 5, 6 and 7 were used, 
and these are listed in Table 5.3. 
Table 5.4: Calculated Σσ- and σ* Values Used to Plot Figures 5.5 and 5.6  
Chemical pEC 3 Hammett Constant 
 (Σσ-) 
Taft Constant 
(σ*) 
BQ 1.36 0 0.49 
2,5-DCBQ 1.88 -0.89 10.95* 
2,6-DCBQ 1.55 -1.33 5.92 
2-CBQ 1.41 -1.57 2.96 
2-MBQ 0.62 -1.63 - 
2,5-DMBQ 0.74 -1.77 - 
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 Quantitative mechanistic modeling that correlates skin sensitization potency and 
quantiﬁed by murine local lymph node assay (LLNA) EC3 data on a range of MA and 
SVN domain electrophiles was used. The model takes the form pEC3 = a∑σ- + c for 
Hammett constants or pEC3 = bσ*+ c for Taft constants (a, b, c and d being constants).97  
This model is based on the Hammett σ- constant of the activating groups (Y) and the Taft 
σ* constants of the leaving groups (X).  Figure 5.2 shows the test chemicals used with  
compounds 2, 3 and 4 having the  deactivating groups (methyl and tert-butyl groups), 
compounds 5, 6 and 7 with leaving groups (chlorine atom(s)) and compound 1 (with 
hydrogen) which is the standard. The arrows on the compounds in Figure 5.2 indicate the 
point of attack by soft nucleophile. Schemes 5.1 show the MA reaction mechanisms for Y 
substituents and scheme 5.2 shows the SVN reaction mechanism for X substituents. 
 The MA reaction shown in Scheme 5.1 depends on the effectiveness of the Y 
group to stabilize a negative charge on the carbon atom to which it is bound. Substituents 
on the α- and β-carbon atoms can have strong influences on Michael reactivity. Electron-
donating substituents such as methyl groups reduce reactivity of compounds in the MA 
domain, by an electronic effect and at times by steric effect depending on the size of the 
substituent.
98
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Scheme 5.1: Michael addition reaction mechanism for methyl/tert-butyl substituted 
benzoquinone derivatives with thiol containing proteins 
 
 
                                   
 
 
Scheme 5.2: Nucleophilic vinylic substitution reaction mechanism for chlorine 
substituted benzoquinone derivatives with thiol containing proteins 
 
 For present purposes, we define a strong activating group as an electronegative 
substituent (X), ortho or para to the leaving group that is able to stabilize a negative 
charge both by resonance and inductive effects. We also used ortho or para chloro group 
as an example of a strong activating group. The ability of  X to stabilize the negative 
charge created in the transition state, when the bond between the attacking nucleophile in 
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not fully formed depends on its inductive effect which is modeled by Taft constant.
99
 If 
this was the only effect to be considered, then we expected 2,6-DCBQ and 2,5-DCBQ to 
have different Taft constants because difference in inductive effects of meta and para 
chloro substituent(s). 
Figure 5.5: Plot of pEC3 vs Taft Constant (Σσ*) for test compounds 1, 5, 6 and 7. 
 
We got an equation of the linear plot of pEC3 against σ* for test compounds 1, 5, 6 and 7 
as shown in Figure 5.6. The equation A4 is as follows,                                                            
                          pEC3 = 0.07(± 0.04) σ* + 1.28(0.18)                                   (5.4)              
                        n = 4, R
2
 = 0.60, R
2
adj = 0.40, s = 0.18, F = 3.08           
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 Equation 5.4 is a QMM for LLNA skin sensitization potency of MA nucleophiles. Figure 
5.5 shows the how equation 5.4 was obtained from the Taft constants of BQ and chloro 
BQD. Equation 5.4 had R
2
 value of 0.60, and this lower correlation constant is due to the 
fact that 2,5-DCBQ and 2,6-DCBQ are treated as if they have the same reactity by Taft 
constants and yet LLNA EC3 values and the reactivity constants suggest that 2,5-DCBQ 
is more reactive than 2,6-DCBQ. The order of the influence of the leaving group was 2,5-
DCBQ = 2,6-DCBQ> 2-CBD >BQ and this agreed with the order of reactivity of the 
EWG BQD to NBT.   
   In the other model a different combination of activating groups (test compound 2, 
3, 5, 6 and 7) were used. Regression analysis for the plot in Figure 5.6 using pEC3 
against Σσ- gave the following equation: 
          pEC3 = 1.34(± 0.37)∑σ- + 3.18(± 0.56)                                             (5.5) 
                       n = 5, R
2
 = 0.76, R
2
adj = 0.70, s = 0.26, F = 12.83 
  This equation (5.5) is a QMM for LLNA skin sensitization potency for SVN and MA 
nucleophiles. Equations 5.4 and 5.5 together with equation 5.1 should act as the first 
screening line for skin sensitizers which belong to MA and SVN domains, without the in-
chemico studies. 
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Figure 5.6: Plot of pEC3 vs Hammett Constant (σ-) for test compounds 2, 3, 5, 6 and 7. 
 
5.3 DISCUSSION 
 
 The BQ moiety common to all test chemicals within this series was considered 
important to allow an accurate comparison of the reactivity to NBT as well as allergenic 
potency in the LLNA while avoiding potential confounders that may arise from structural 
differences. From the LLNA data and prediction of EC3 values using rate constants, we 
observed that BQD with electron withdrawing groups had the highest chemical potency 
followed by unsubstituted BQ and the least potent were the BQD with electron donating 
groups.  This trend agreed well with what was expected because electron-donating 
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substituents such as methyl groups reduce reactivity while electron withdrawing 
substituents such as halogens increase reactivity of compounds in the MA domain.
98
 It is 
particularly striking that a relatively small changes in the BQ structure have a dramatic 
impact on the LLNA EC3. This is observed when the LLNA EC3 decreases with 
increasing number of chlorine atoms added to BQ (BQ > CBQ>DCBQ). The effect of 
different positions on reactivity is observed between 2,5-DCBQ and 2,6-DCBQ in which 
2,5-DCBQ (EC3= 0.013 %) was 2.15 times more reactive than the 2,6-DCBQ (EC3= 
0.028 %). This is because the para- substituted EWG inductive influence on the leaving 
group is greater than the meta substituted EWG.  
The mono-BQD was less reactive than the DCBQ because BQD both EWGs on DCBQ 
contribute to and thus increases the inductive effect over the mono-chloro BQD. The 
other reason why DCBQs are apparently more reactive than mono-BQD is because of the 
DCBQs bind at a 1:2 ratio with protein thiols versus the 1:1 protein thiol binding of  
mono-BQD.
95
 
 As pointed out by Roberts and Aptula ( 2008),
100
 if kp and kr  are the rate 
constants for penetration and reaction with carrier protein respectively, and (D) is the 
concentration of sensitizer applied at the skin surface, then the extent of carrier protein 
binding PB after time (t) is given by:     
            PB = D{1 + [kr exp(-kpt) – kp exp( -krt)]/(kp – kr)}                               (1) 
Since both penetration rates and reaction rates for sensitizers can range over several 
orders of magnitude, in the vast majority of cases either kp » kr or kp « kr will apply. 
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Where penetration is faster than protein reactivity, i.e. kp » kr , the expression is simpliﬁed 
to:  
                          PB = D{1 + exp(-kpt)]}                                                          (2) 
i.e. the extent of protein binding is dependent on the reaction rate but not on the 
penetration rate.
98
 The weakest allergen in this study 2,5-DMBQ has an EC3 of 0.181 % 
which could be considered an extreme sensitizer and would fall in the situation where kp 
» kr . The reported order of reactivity of chlorine substituted BQs to NBT matched the 
chemical potency in LLNA and partition coefficient (log P), i.e. BQ (log P = 0.497), 
CBQ (log P = 0.980), 2,6-DCBQ (log P = 1.338) and then 2,5-DCBQ (log P = 1.341). 
For the situation where the reaction is faster than penetration, i.e. kp « kr , the expression 
is simpliﬁed to:  
                          PB = D{1 -  exp(-kpt)]}                                                      (3)  
i.e. the extent of protein binding in the skin has greater dependence on the penetration 
rate than the reaction rate. 
100
 We also observed the following trend in electron magnetic 
resonance signal, BQ < CBQ < 2,6-DCBQ < 2,5-DCBQ, and this is the same trend that 
LLNA EC3 values a following. We concluded that BQ radical may be playing a minor 
role in haptenation of protens.
101
 This agrees well with what was previously suggested by 
Christensson et al. (2006),
74
 that  semiquinone radicals may act as a hapten. 
 From the predicted pEC3 values listed in Table 5.2, equation 5.1 over estimates 
the chemical potency of the BQ and EWG BQD by 30 to 2000 fold.  Potential  reasons 
for the limited accuracy of equation 5.1 in predicting EC3 values include a potential error 
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introduced by inclusion of multiple mechanistic domains, the influence multiple 
intermediate species, and chemicals with multiple electrophilic moieties. The published 
predictive equation also covered a wider range of chemical solubility’s, reactivities and 
allergenic potencies.  It must also be noted that BQ was the most reactive allergen in the 
data set reported by Chipinda et. al.
71
 and the predicted values for the chloro-
benzoquinones were extrapolated beyond the tested data set.  This assumed log-log 
linearity of pEC3 vs. log Ka at the fastest reaction rates and this assumption may not have 
been correct. 
 Figure 5.4 and equation 5.1 shows that LLNA of these benzoquinone derivatives 
are dependent on reactivity alone, and no hydrophobicity parameter is needed to model 
the data. This has been previously observed that the same applies for the Michael 
acceptor domain: LLNA is dependent on reactivity but not on hydrophobicity.
102
 The low 
value on log k coefficients suggests that the biological nucleophiles are 6 times less 
selective than NBT which was used in this model. Another possibility is that the relevant 
in vivo nucleophile is based on the selenocysteine, which is known to be present in the 
skin protein subunit.
103
 The ionized SeH functional group is even softer nucleophile than 
ionized SH group.
92
 The good correlation(R
2
 = 0.74) of equation 5.1 to the in vivo data 
shows that it is not to use nucleophiles designed to closely resemble the in vivo 
nucleophiles for models.  
 The influence of the activating groups was modeled by the sum of their (σ-) 
values, (∑σ-).  The calculated sum of the Hammett constants (∑σ-), predicted that the 
order of influence of the substituents on BQ will follow the order, 2,5-DCBQ > 2,6-
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DCBQ > 2-CBQ > 2-MBQ > 2,5-DMBQ and this agrees well the order of reactivity 
constants listed in Table 3.2. When pEC3 (LLNA) were plotted against Hammett 
constants (∑σ-), equation 5.5 was observed whose R2 = 0.76, and this is close the R2 
(0.74) obtained in equation 5.1. These correlation coefficients were lower than what we 
obtained from equation 5.4 (Taft constants) because Taft constants treats 2,5-DCBQ and 
2,6-DCBQ as if have the same reactivity and yet LLNA EC3 values and reaction rate 
constants suggests that they are have different reactivities. The good correlation between 
reactivity predictions using Hammett constants, NBT reactivity rate constants and EC3 
estimates suggests that Hammett constants, where available, may provide good estimates 
of chemicals’ relative skin sensitization potency. 
5.4 CONCLUSION 
 
It is generally accepted that chemical allergens must first bind to a protein to be 
allergenic.  The high correlation between chemical reactivity as demonstrated empirically 
using the NBT assay, or through modeling using Hammett constants and the LLNA 
threshold EC3 estimates of the BQ and BQD series suggest that the rate of chemical-to-
protein binding is a major determinant of skin sensitization potency.  Influence of other 
factors physical-chemical factors such as log P, mechanistic domain, and haptenated 
protein stability on a chemical’s skin sensitization potency remains to be determined and 
may vary between chemical classes.  Skin sensitization to chemicals present in consumer 
products and the workplace continues to be a major concern. The accuracy of the 
prediction model proposed exceeded that of the LLNA for set of substances tested. EC3 
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measurements are reproducible in both intra- and inter-laboratory evaluations and are 
stable over time which make reactivity model reliable for to determine relative potency, 
so that potential skin sensitizers may be ranked and to provide a key input for skin 
sensitization  risk assessment. These models are very promising results point to a possible 
future replacement of animal testing while maintaining the same degree of accuracy and 
predictivity for human skin sensitizers.
104
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